3D culture method for large-scale production of stem cells
The three-dimensional microcarrier-based cell culture method addresses the limitations of two-dimensional methods by enhancing production efficiency and stability, enabling large-scale, standardized stem cell production for therapeutic applications.
Patent Information
- Application Number
- KR1020217027722
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-08-30
- Filing Date
- 2019-10-14
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2039-10-14
AI Technical Summary
Current two-dimensional artificial culture methods for stem cells are labor-intensive, difficult to standardize, and unable to produce large volumes consistently, leading to high costs and safety issues due to unstable cell quality, making it challenging to meet the demands of stem cell therapies.
A three-dimensional microcarrier-based cell culture method involving cell recovery, adhesion, harvesting, and sampling techniques, including cryopreservation, dynamic and static culture methods, and large-scale expansion using stirred bioreactors to enhance production efficiency and consistency.
Enables large-scale, standardized production of stem cells with improved stability and safety, facilitating the development of stem cell therapies by simplifying operations and reducing manual handling.
Smart Images

Figure 112021106636908-PCT00004_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to the field of cell culture, and in particular to a three-dimensional (3D) culture method for the large-scale production of stem cells. Background Technology
[0002] Stem cells are a type of pluripotent cell capable of self-replication that, once induced under appropriate conditions, can differentiate into various functional cells such as neuronal cells, cardiomyocytes, vascular endothelial cells, renal cells, and hepatocytes. With the advancement of stem cell research, their medical value is limitless, and their potential for clinical application is having a tremendous impact on the progress of medicine. Several studies have demonstrated that stem cells and their secretions play a role in the treatment of various diseases such as tumors, spinal cord injury, multiple sclerosis, stroke, amyotrophic lateral sclerosis, Alzheimer's disease, osteoarthritis, femoral head necrosis, disc degeneration, myocardial infarction, cirrhosis, Crohn's disease, interstitial lung disease, systemic lupus erythematosus, erectile dysfunction, and premature ovarian failure.Stem cells that can be used in regenerative medicine include, but are not limited to, mesenchymal stem cells (MSC), embryonic stem cells (ESC), adipocyte stem cells (ADSC), neural stem cells (NSC), and induced pluripotent stem cells (iPSC), among which MSCs are the most widely used clinically.
[0003] Stem cells are considered "drugs" for management and approval in many countries around the world. Currently, 14 stem cell therapies are being sold globally, but no products have yet been approved in China. However, since 2018, as China's stem cell products began to be regulated under the Pharmaceutical Supervision and Administration, several stem cell drugs have received approval from the National Medical Products Administration (NMPA), with three of them receiving approval for IND (Investigational New Drug) entry into clinical trials. At the same time, 51 stem cell clinical trials were submitted to the National Health Commission and approved. These figures indicate that China is entering a stage of rapid development in the development and translation of stem cell drugs.
[0004] Stem cells and cell products derived from stem cells have long been considered difficult to develop into pharmaceuticals due to characteristics such as heterogeneity and changes in activity. Compared to traditional "chemical drugs," "proteins, nucleic acids," and other biological drugs, the production and preparation of emerging cell drugs are more complex and challenging. However, the production processes for stem cell products currently sold domestically, as well as those for clinical or research use, still rely on traditional two-dimensional artificial culture manufacturing processes. These manufacturing methods depend on open processes involving a large number of tasks, cumbersome steps, and excessive labor-intensive processes, making it difficult to standardize operations and produce the large volumes of cells required to meet the demands of various cell therapies. In addition to high costs and the need for extensive production space, the limited number of batches of cell products produced, coupled with safety issues stemming from the unstable quality of stem cells in each batch due to uncertainties and uncontrollable factors in each process, all raise doubts about the potential of stem cells as drugs for large-scale applications. Therefore, when cells are formulated into marketable commercial products in the future, a production batch of more than 10¹¹ cells may be required. In particular, when cell products require multiple high doses to achieve therapeutic effects, existing production processes cannot consistently supply such quantities in a timely manner. Therefore, it is urgent to devise methods that simplify operations, reduce manual handling, and enable large-scale closed or semi-closed stem cell cultures, which are key factors in driving the stem cell therapy industry and enabling clinical-grade stem cell preparations.
[0005] The present invention provides a three-dimensional culture method for the large-scale production of stem cells.
[0006] The present invention relates to a three-dimensional microcarrier-based cell recovery method and a three-dimensional microcarrier cell culture-based on site Subdivision method and on siteProvides a set of three-dimensional microcarrier-based cell culture methods including cell culture based on a three-dimensional microcarrier of cell cryopreservation;
[0007] A three-dimensional microcarrier-based cell recovery method comprises the step of inoculating a cell suspension of thawed and cryopreserved cells or cryopreserved cell microtissues onto a three-dimensional microcarrier for cell recovery and culture;
[0008] A 3D microcarrier-based in situ subdivision method comprises the following steps: inserting a seed microcarrier into a new microcarrier; the seed microcarrier is a microcarrier cultured with the cells to be subdivided;
[0009] 3D microcarrier-based on site The cell cryopreservation method includes the following steps:
[0010] (A1) A step of centrifuging a three-dimensional microcarrier suspension of cells and discarding the supernatant to obtain a cell-containing carrier;
[0011] (A2) A step of mixing the cell-containing carrier obtained in step (A1) with a cryopreservation solution and adding it to a cryogenic storage tube;
[0012] (A3) A step of cooling the cryogenic storage tube containing the cell carrier added in the above (A2) step and then transferring it to liquid nitrogen; the cell in the three-dimensional microcarrier on site It can be frozen and preserved.
[0013] The above method further comprises a method for cell adhesion culture on a three-dimensional microcarrier, a method for harvesting cells on a three-dimensional microcarrier, and a method for sampling cells cultured on a microcarrier; the method for cell adhesion culture on a three-dimensional microcarrier is used to inoculate cells onto a three-dimensional microcarrier. The method for harvesting cells from a three-dimensional microcarrier is used to detach cells from a three-dimensional microcarrier. The method for sampling cells cultured on a microcarrier is used to perform calculations of the total number of cells and / or cell density of cells cultured on a microcarrier.
[0014] A method for culturing cell attachment on a three-dimensional microcarrier comprises the following steps: (B1) Cell inoculation: a step of mixing a cell suspension with a dried three-dimensional microcarrier to obtain a microcarrier mixed with the cell suspension; (B2) Cell attachment: a step of culturing the microcarrier mixed with the cell suspension obtained in step (B1) to allow cells to attach to the three-dimensional microcarrier; (B3) Cell culture: after cell attachment in step (B2), complete culture medium is added and cultured.
[0015] A method for harvesting cells on a three-dimensional microcarrier comprises the following steps: (C1) naturally settling or centrifuging a three-dimensional microcarrier to which cultured cells are attached, and removing the supernatant to obtain a three-dimensional microcarrier containing cells; (C2) adding a lysis solution to the three-dimensional microcarrier containing cells, and culturing and dissolving the three-dimensional microcarrier inside; (C3) after completely dissolving the three-dimensional microcarrier in step (C2), adding a termination solution to terminate the dissolution or proceeding directly to step (C4) to terminate the dissolution; (C4) centrifuging the system obtained in step (C3) to discard the supernatant and harvesting cells on the three-dimensional microcarrier.
[0016] A method for sampling cells cultured on a microcarrier comprises the following steps: (D1) measuring a specific weight of microcarriers for cell culture, placing them in a sampling tube, adding liquid to simulate the cell culture process, immersing them at 4 to 60°C for 0 to 24 hours, and marking a scale corresponding to the volume occupied by the microcarriers on the sampling tube as a standard scale; (D2) sampling the cells cultured on the microcarriers as follows: sampling the microcarriers from the cell culture system into a sampling tube to make the volume of the microcarriers a reference scale.
[0017] In a 3D microcarrier-based cell recovery method, the cryopreserved cell microtissue is cells cryopreserved within a 3D microcarrier. 0.1–25X10 per mg of cryopreserved microtissue 6 There are several cells. In an embodiment of the present invention, 0.25 x 10 microstructures per mg 6 There are dogs' cells.
[0018] The 3D microcarrier-based cell recovery method is a 3D microcarrier-based dynamic cell recovery method or a 3D microcarrier-based static cell recovery method.
[0019] A dynamic cell recovery method based on a 3D microcarrier comprises the following steps: (E1) taking a 3D microcarrier, placing it in a cell culture vessel, adding cell culture medium, and immediately proceeding to the next step or processing for at least 1 minute; processing methods include standing or stirring; (E2) inoculating a cell suspension of cryopreserved cells or cryopreserved cell microtissues thawed at 37°C into a cell culture vessel containing the microcarrier prepared in (E1), adding cell culture medium and adjusting the ratio of microcarrier to medium to 1 mg: 1 to 1000 μL; placing the cell culture vessel on a stirrer and stirring in an incubator; (E3) after the completion of (E2), continuing to stir the cells until cell recovery is complete.
[0020] A static cell recovery method based on a 3D microcarrier comprises the following steps: (F1) preparation of a static culture vessel and a microcarrier: taking a 3D microcarrier and placing it in a cell culture vessel; (F2) thawing and inoculation of cryopreserved cells: taking a cryopreserved cell or cryopreserved cell microtissue, thawing it at 37°C, and then inoculating it into a static culture vessel containing the microcarrier prepared in (F1) for 20 to 240 minutes; (F3) after the completion of (F2), continuing cell culture until cell recovery is completed.
[0021] In step (E1), the cell culture medium may be added and left for 1 to 10 minutes. In one embodiment of the present invention, the standing time is 10 minutes.
[0022] In step (E1), the volume of cell culture medium added is 0 to 50% of the medium volume during stirring and recovery in step (E2). In one embodiment of the present invention, the volume of cell culture medium added is 1 / 6 of the medium volume during stirring and recovery in step (E2).
[0023] In step (E2), the volume of the cell suspension after thawing is 1 to 100% of the volume of the medium during stirring and recovery in step (E2). In one embodiment of the present invention, the volume of the cell suspension during stirring and recovery in step (E2) is 1 / 30 of the volume of the medium. The cell concentration in the cell suspension is 5 to 500 x 10⁵ cells / mL. In an embodiment of the present invention, the cell concentration in the cell suspension is 1 x 10⁶ 6 It is cells / mL.
[0024] In step (E2), cells or cellular microtissues are 5-100 x 10⁻⁶ per mg of microcarrier 3 Cells are inoculated into a cell culture vessel containing a microcarrier at a ratio of the number of cells to the number of cells in the microcarrier. In one embodiment of the present invention, the ratio of the number of cells to the new microcarrier is 10 4 The ratio of microcarrier to medium is 1 mg of cell / microcarrier; the ratio of microcarrier to medium is adjusted to 1 mg:300 μL by adding cell culture medium.
[0025] In step (E2), stirring is constant speed stirring, variable speed alternating stirring, or variable speed cyclic stirring.
[0026] Stirring is clockwise stirring, counterclockwise stirring, or alternating stirring.
[0027] The stirring time is 0.1 to 100 hours (e.g., 96 hours).
[0028] The stirring speed is 1 to 200 rpm. The stirring speed is preferably 5 to 80 rpm, more preferably 10 to 60 rpm.
[0029] In addition, the stirring recovery is performed as in (a) or (b) or (c) below:
[0030] (a) a step of leaving for 1 to 4 hours, then stirring clockwise at a variable circulation speed for 1 to 24 hours, and then stirring clockwise at a constant speed up to 96 hours;
[0031] (b) a step of stirring clockwise at a variable circulation speed for 1 to 24 hours, followed by stirring clockwise at a constant speed for up to 96 hours;
[0032] (c) A step of stirring clockwise at a constant speed for 1 to 96 hours.
[0033] In one embodiment of the present invention, stirring is performed by leaving the mixture for 4 hours, then stirring clockwise at a cyclic variable speed with a cycle of 40 rpm for 5 minutes and 20 rpm for 20 minutes up to 24 hours, and then stirring clockwise at a constant speed (60 rpm) up to 96 hours.
[0034] In one embodiment of the present invention, stirring is performed by stirring at 40 rpm for 5 minutes and at 20 rpm for 20 minutes for 24 hours in a cyclic variable manner, and then stirring at a constant speed (60 rpm) in a clockwise direction for up to 96 hours.
[0035] In one embodiment of the present invention, stirring is performed clockwise at a constant speed (60 rpm) until 96.
[0036] For the stirring method in step (E3), refer to the previous section. In one embodiment of the present invention, stirring is performed clockwise at a constant speed (60 rpm).
[0037] In steps (E1) to (E3), the cell culture vessel is a vessel capable of stirring and suspending a microcarrier. In one embodiment of the present invention, the cell culture vessel used is a cell culture flask (Bellco Glass, USA; Catalog No.: 1965-61001) with an impeller built in.
[0038] In step (F2), the ratio of microcarriers to cells is 5 to 100×10 3 It is a cells / mg microcarrier. In one embodiment of the present invention, the ratio of the number of cells to the new microcarrier is 10,000 cells / mg microcarrier.
[0039] Step (F2) involves adding cell culture medium after cell inoculation to adjust the ratio of medium to microcarrier to 100-400 μL : 20 mg. In one embodiment of the present invention, the ratio of cell culture medium to microcarrier is 200 μL : 20 mg.
[0040] In one embodiment of the present invention, the incubation time is 240 minutes.
[0041] In the above 3D microcarrier-based cell recovery method, the 3D microcarrier is a 3D porous microcarrier. Specifically, the 3D porous microcarrier may be a 3D TableTrix microcarrier (Beijing CytoNiche Biotech Ltd.; Catalog No.: F01-100).
[0042] 3D microcarrier cell culture-based on siteIn the passage method, the new microcarrier is a microcarrier that does not contain cells. The seed microcarrier has a cell density of 10,000 to 1,000,000 cells / mg microcarrier (e.g., 100,000 to 500,000 cells / mg microcarrier, or 120,000 to 500,000 cells / mg microcarrier). The ratio of the seed microcarrier to the new microcarrier is 0.0002 to 200 mg seed microcarrier / mg new microcarrier (e.g., 2 to 15 mg seed microcarrier / 100 mg new microcarrier).
[0043] In addition, the seed microcarrier is 120,000 to 500,000 cells / mg microcarrier (static as described below) on site Particularly suitable for passage) or 150,000 to 500,000 cells / mg microcarrier (dynamic described below) on site It has a cell density that is particularly suitable for passage. The ratio of seed microcarrier to new microcarrier is 1 to 3 mg seed microcarrier / 20 mg new microcarrier (static as described below). on site Particularly suitable for passage) or 2 to 6.7 mg seed microcarrier / 100 mg new microcarrier (dynamic described below) on site It is particularly suitable for lineage.
[0044] 3D microcarrier cell culture-based on site The subculture method is a dynamic in situ subculture based on 3D microcarrier cell culture or a static subculture based on 3D microcarrier cell culture. on site It is the generational method.
[0045] 3D microcarrier cell culture-based dynamics on siteThe subculturing method comprises the following steps: (G1) preparation of a new microcarrier suspension: placing a new microcarrier into a cell culture flask equipped with an impeller, adding cell culture medium in a ratio of 1 to 2,000 μL: 1 mg microcarrier, and standing or stirring for at least 0 hours to obtain a new microcarrier suspension; (G2) preparation of a seed microcarrier suspension: the seed microcarrier has a cell density of 10,000 to 1 million cells / mg microcarrier, and resuspending the seed microcarrier in cell culture medium at a concentration of 0.1 to 50 mg / mL to obtain a seed microcarrier suspension; (G3) Inoculation: Mixing the seed microcarrier suspension prepared in (G2) into a cell culture flask equipped with an impeller containing the new microcarrier suspension prepared in (G1), adjusting the ratio of seed microcarrier to new microcarrier to 0.0002 to 200 mg seed microcarrier / mg new microcarrier, adding cell culture medium to adjust the microcarrier to medium ratio to 1 mg:1 to 1000 μL, placing the cell culture flask equipped with an impeller on a stirrer, and placing it in an incubator to stir for 0 to 100 hours; (G4) Culture: Dynamic on site The stage of continuously stirring to complete the subdivision.
[0046] A static in situ subduction method based on 3D microcarrier cell culture comprises the following steps: (H1) Preparation of seed microcarrier suspension: the seed microcarrier has a cell density of 10,000-1,000,000 cells / mg, and the seed microcarrier is resuspended in cell culture medium at a concentration of 0.1 to 50 mg / mL to obtain a seed microcarrier suspension; (H2) Inoculation: the seed microcarrier suspension prepared in (H1) is added dropwise to a new microcarrier, the ratio of seed microcarrier to new microcarrier is 0.0002-200 mg seed microcarrier / mg new microcarrier, and after thorough mixing, the sample is placed in an incubator and cultured for 0.5-24 hours; (H3) Culture: cell culture medium is added and culture is continued, i.e., the static in situ subduction is completed.
[0047] In step (G1), the ratio of new microcarrier to cell culture medium in a cell culture flask with an impeller may be 100 mg microcarrier / 10 mL cell culture medium; and the new microcarrier and cell culture medium may be left for 0.1 to 24 hours (in a specific embodiment of the present invention, the standing time is specifically 14 hours) after being placed in the cell culture flask with an impeller.
[0048] In step (G2), the cell density of the seed microcarrier may be 150,000 to 500,000 cells / mg of microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension may be 1 to 10 mg / mL (in a specific embodiment of the present invention, the content of the seed microcarrier in the seed microcarrier suspension is specifically 1 mg / mL).
[0049] In one embodiment of the present invention, the cell density of the seed microcarrier is specifically 500,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension is specifically 1 mg / mL.
[0050] In one embodiment of the present invention, the cell density of the seed microcarrier is specifically 150,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension is specifically 1 mg / mL.
[0051] In step (G3), the ratio of seed microcarrier to new microcarrier may be 1 to 10 mg seed microcarrier / 100 mg new microcarrier (e.g., 2 to 6.7 mg seed microcarrier / 100 mg new microcarrier); the ratio of microcarrier to medium may be adjusted to 1 to 10 mg:1 mL (e.g., 106.7 to 204 mg:60 mL) by adding cell culture medium; the stirring speed may be 1 rpm to 200 rpm, stirring may be performed by constant speed stirring, variable speed alternating stirring, or variable speed cyclic stirring, and the stirring direction may be clockwise stirring, counterclockwise stirring, or alternating stirring. Cells on the seed microcarrier are transferred to the new microcarrier.
[0052] In an embodiment of the present invention, the ratio of seed microcarrier to new microcarrier is specifically 2 mg seed microcarrier / 100 mg new microcarrier; the ratio of microcarrier to medium is specifically adjusted to 204 mg:60 mL by adding cell culture medium; and the stirring is variable speed cyclic clockwise stirring using specific parameters of 60 rpm for 5 minutes and 20 rpm for 20 minutes in a total cycle of 24 hours.
[0053] In an embodiment of the present invention, the ratio of seed microcarrier to new microcarrier is specifically 6.7 mg seed microcarrier / 100 mg new microcarrier; the ratio of microcarrier to medium is specifically adjusted to 106.7 mg:60 mL by adding cell culture medium; and the stirring is variable speed cyclic clockwise stirring using specific parameters of 60 rpm for 5 minutes and 20 rpm for 20 minutes in a total cycle of 24 hours.
[0054] In step (H1), the cell density of the seed microcarrier may be 120,000 to 500,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension may be 5 to 15 mg / mL.
[0055] In one embodiment of the present invention, the cell density of the seed microcarrier is specifically 500,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension is specifically 5 mg / mL.
[0056] In one embodiment of the present invention, the cell density of the seed microcarrier is specifically 120,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension is specifically 15 mg / mL.
[0057] In addition, at step (H2), the ratio of seed microcarrier to new microcarrier may be 1 to 3 mg seed microcarrier / 20 mg new microcarrier; and the culture time may be 0 to 24 hours.
[0058] In an embodiment of the present invention, the ratio of seed microcarrier to new microcarrier is specifically 1 mg seed microcarrier / 20 mg new microcarrier; and the incubation time is specifically 2 hours.
[0059] In an embodiment of the present invention, the ratio of seed microcarrier to new microcarrier is specifically 3 mg seed microcarrier / 20 mg new microcarrier; and the incubation time is specifically 2 hours.
[0060] In an embodiment of the present invention, the ratio of seed microcarrier to new microcarrier is specifically 3 mg seed microcarrier / 20 mg new microcarrier; and the incubation time is specifically 2 hours.
[0061] 3D microcarrier cell culture-based on siteIn the subculturing method, the microcarrier is the 3D FloTrix microcarrier (Beijing CytoNiche Biotech Ltd.; Catalog No.: CNF-F01T-50). The cell culture flask with a built-in impeller is a product of Bellco Glass, USA, Catalog No.: 1965-61001. The stirrer is a low-speed stirrer (3D FloTrix miniSpin low-speed stirrer, Beijing CytoNiche Biotech Ltd., Catalog No.: 3D FTmS-2-2).
[0062] 3D microcarrier-based on site In the cell cryopreservation method, in step (A1), centrifugation is performed at a speed of 50 to 1610 ghg, specifically 400 ghg, for a time of 1 to 10 minutes, specifically 2 minutes. In step (A2), the ratio of the volume of the cryopreservation solution to the mass of the cell-containing carrier is 1 mL: 0.1 to 50 mg, specifically 1 mL: 10 mg or 1 mL: 0.1 to 20 mg.
[0063] 3D microcarrier-based on site In a cell cryopreservation method, the cryopreservation solution comprises 10% DMSO, 10–90% FBS and 0–80% basal medium, 10% DMSO and 0–80% basal medium, 10–90% FBS and 0–80% basal medium, or other commercially available cell cryopreservation solutions such as CF0101 Cellregen serum-free Cell Cryopreservation Solution.
[0064] 3D microcarrier-based on site In a cell cryopreservation method, a cryogenic storage tube is placed in a refrigerator and cooled to -20 to -196°C, specifically -20 to -80°C. Cooling is programmed or not programmed. Programmed cooling has a cooling rate of -1 to -15°C / min. The cooling time may be 1 to 24 hours, specifically 24 hours, 10 to 24 hours, or 15 to 24 hours.
[0065] 3D microcarrier-based on site The cell cryopreservation method is to place the cryogenic storage tube of step (A2) into a cell cooling box and cool it in a refrigerator within 1 to 10 minutes.
[0066] 3D microcarrier-based on site In a cell cryopreservation method, PBS or basic medium preheated to 37°C and added to a cryogenic storage tube is diluted in a ratio that can be 1:5 to 30.
[0067] 3D microcarrier-based on site In the cell cryopreservation method, the cell retrieval step after step (A3): the cryopreservation tube processed in step (A3) is placed in a water bath to retrieve the cells, and the water bath is removed when the ice in the cryopreservation tube melts; then, PBS or basic medium preheated to 37°C is added, and then the cells are diluted by centrifugation.
[0068] 3D microcarrier-based on site In the cell cryopreservation method, the temperature of the water bath can be 35 to 40°C; the bath time is 1 to 5 minutes.
[0069] 3D microcarrier-based on site In the cell cryopreservation method, when the cell is recovered after step (A3), the centrifugation rate may be 50 to 1610 ghg, specifically 400 ghg, for a time of 1 to 10 minutes, specifically 2 minutes.
[0070] In a cell adhesion culture method on a three-dimensional microcarrier, the density of the cell suspension is 1×10 4 Up to 1X10 8cells / mL; the cell suspension is obtained by resuspending cells in a culture medium or a liquid biological matrix material, wherein the material may be specifically selected from the group consisting of collagen, gelatin, gelatin derivatives, proteoglycans, glycoproteins, alginate, alginate derivatives, agar, matrix gum, hyaluronic acid, fibronectin, or laminin. The volume ratio of the cell suspension to the mass of the three-dimensional microcarrier is 1 to 1000 μL : 1 mg; Specifically, it may be 10 μL: 1 mg, 1 to 10 μL: 1 mg, 10 to 15 μL: 1 mg, 5 to 15 μL: 1 mg, or 250 to 350 μL: 1 mg.
[0071] In a method for cell attachment culture on a three-dimensional microcarrier, in step (B1), the cell suspension is mixed with the three-dimensional microcarrier as follows: the cell suspension is added to the three-dimensional microcarrier. In step (B1), the cell suspension is mixed directly using a dried three-dimensional microcarrier, so there is no need to pre-swell the three-dimensional microcarrier, making it simple to inoculate the cells onto the microcarrier.
[0072] In a method for cell attachment culture on a three-dimensional microcarrier, the culture conditions may be as follows: a temperature of 35 to 40°C, specifically 37°C, 37 to 40°C, or 35 to 37°C; a period of 0.5 to 24 hours, specifically 2 hours or 24 hours; a volume-based carbon dioxide concentration percentage of 5 to 30%, specifically 5%, 5 to 10%, or 5 to 20%. Attachment methods include gravity attachment, swelling attachment, agitator rotation attachment, centrifugation, surface acoustic wave, or magnetic attachment.
[0073] In a method for cell attachment culture on a three-dimensional microcarrier, the culture conditions are as follows: the temperature may be 35 to 40°C, specifically 37°C, 37 to 40°C, or 35 to 37°C, and the percentage of carbon dioxide concentration by volume may be 5 to 30%, specifically 5%, 5 to 10%, or 5 to 20%.
[0074] In a method for cell attachment culture on a three-dimensional microcarrier, step (B1) is preceded by a step of gas sterilizing, radiation sterilizing, or UV sterilizing the three-dimensional microcarrier.
[0075] In the method of cell attachment culture on a three-dimensional microcarrier, the three-dimensional microcarrier is a porous microcarrier, specifically a 3D FloTrix microcarrier, which is commercially available from Beijing CytoNiche Biotech Ltd. under catalog number: CNF-F01T-50. Cytopore 1 and Cytopore 2, catalog number: 17-0911, are commercially available from GE, and CultiSpher (M9418), catalog number: 17-1271, is commercially available from Sigma.
[0076] In a method for harvesting cells on a three-dimensional microcarrier, the lysis solution comprises an active ingredient for lysing the microcarrier while removing cell adhesion. The active ingredient is selected from at least one aqueous solution of collagenase, pepsin, hyaluronidase, dispase, neutral protease, proteinase K, matrix metalloproteinase, sodium citrate, trypsin, deoxyribonuclease, trypsin substitute, protein hydrolase, ethylene diamine tetraacetic acid, lysozyme, and glutathione. In one embodiment, the dissolution solution formulation comprises 0.1% (mass percentage) collagenase, 0.1% (mass percentage) ethylenediaminetetraacetic acid, and 0.05% (mass percentage) trypsin.
[0077] In a method for harvesting cells on a three-dimensional microcarrier, the termination solution is selected from at least one of whole medium, PBS containing 10% serum albumin or serum, trypsin inhibitors, protease inhibitors, PBS, and ionic chelating agents, depending on the composition of the selected lysis solution. Specifically, the ionic chelating agent may be ethylene diamine tetraacetic acid.
[0078] In a method for harvesting cells on a three-dimensional microcarrier, in step (C1), centrifugation may be performed at a speed of 50 to 1610xg, specifically 200xg, for 1 to 10 minutes, specifically 2 minutes. The step of removing the supernatant is as follows: centrifuging and pipetting the supernatant; then adding an appropriate amount of PBS and gently shaking by hand for 20 to 30 seconds, then pipetting the supernatant and repeating the PBS wash once.
[0079] In a method for harvesting cells on a three-dimensional microcarrier, the ratio of the mass of the three-dimensional microcarrier to the volume of the lysis solution for cell attachment and culture may be 1 mg : 0.01 to 5 mL, specifically 20 mg : 3 mL, 1 mg : 0.15 to 0.5 mL, or 1 mg : 0.1 to 2 mL; incubation may be performed at a temperature of 4°C to 40°C, specifically 37°C, for a period of 10 seconds to 24 hours, specifically 30 minutes. In a specific embodiment, during the described incubation period, the process is performed gently by blowing several times using a 1 mL pipette at 10-minute intervals.
[0080] In a method for harvesting cells on a three-dimensional microcarrier, the ratio of the mass of the three-dimensional microcarrier to the volume of the termination solution for cell attachment and culture is 1 mg : 0.01 to 50 mL, specifically 20 mg : 3 mL or 1 mg : 0.1 to 25 mL.
[0081] In a method for harvesting cells on a three-dimensional microcarrier, the centrifugation in step (C4) is at a speed of 50 to 1610 ghg, specifically 400 ghg, for 1 to 10 minutes, specifically 2 minutes or 2 to 8 minutes.
[0082] A method for sampling cells cultured on a microcarrier for calculating the total number of cells cultured on a microcarrier and / or the cell density cultured on a microcarrier comprises the following steps: (D1) measuring a specific weight of a microcarrier for cell culture, placing them in a sampling tube, adding a liquid to simulate the cell culture process, immersing them at 4 to 60°C for 0 to 24 hours, and then marking a scale corresponding to the volume occupied by the microcarrier on the sampling tube as a standard scale; (D2) sampling the cells cultured on the microcarrier as follows: sampling the microcarrier from the cell culture system into a sampling tube to make the volume of the microcarrier a reference scale; (D3) counting the cells within the microcarrier collected in (D2); (D4) calculating the total number of cells in the entire cell culture system based on the weight of the microcarrier weighed in (D1), the number of cells counted in (D3), and the total weight of the microcarrier in the entire cell culture system; and calculating the cell density.
[0083] In step (D1) above, the process of adding a liquid to a sampling tube containing a microcarrier and immersing it at 4 to 60°C for 0 to 24 hours is a process of completely immersing and swelling the microcarrier. The liquid added here may have the same or similar viscosity, hydrophilicity, pH, and ion concentration as the medium of the present invention used for cell culture on the microcarrier (e.g., the medium of the present invention used for cell culture or in PBS). The temperature and time required to immerse and swell the microcarrier vary depending on the microcarrier. This can be performed according to the instructions for microcarriers from other manufacturers. For example, using GE's microcarrier Cytodex 1, the dried microcarrier is swollen by immersing it in PBS at room temperature at a rate of 30-50 mL / g for at least 3 hours. For example, a 3D FloTrix microcarrier (CNF-F01T-50) available from Beijing CytoNiche Biotech Ltd. is immersed in PBS at room temperature for 0.5 to 24 hours and swollen. Specifically, for 6 hours at a ratio of 10 to 1000 μL: 1 mg; specifically, 10 μL: 1 mg, 10 to 15 μL: 1 mg, 5 to 15 μL: 1 mg, or 250 to 350 μL: 1 mg.
[0084] In step (D1), after immersing the microcarrier in the liquid, an additional step of natural sedimentation or centrifugal sedimentation (e.g., centrifugation at 1,500 rpm for 2 minutes) is also included for the purpose of settling the microcarrier as quickly as possible.
[0085] In step (D2), sampling of microcarriers from a cell culture system using a sampling tube may be performed according to a method comprising the following steps: pipetting a suspension from a cell culture system and adding it to a sampling tube; allowing the microcarriers to precipitate naturally or by centrifugation (to accelerate precipitation, centrifugation may be performed at a rate of 50 to 1610 ghg, specifically 200 ghg, for a period of 1 to 10 minutes, specifically 2 minutes); and observing whether the volume of the microcarriers has reached a standard scale corrected in step (D1); if it has not been reached, continuing to pipet the suspension until it reaches the standard scale, and if it has been exceeded, removing the excess microcarriers from the sampling tube.
[0086] In step (D3), the counting of cells in the microcarrier collected in (D2) can be performed according to a method comprising the following steps: centrifuge the sampling tube in (D2) (e.g., 200 kJ / 20
[0087] In step (D4), the total number of cells in the entire cell culture system is equal to the number of cells counted in (D3) multiplied by the ratio of the total weight of the microcarrier to the weight of the microcarrier weighed in (D1).
[0088] In step (D4), the total number is divided by the total weight or total number of microcarriers or the total volume of the culture system to form different units, e.g., cell / mg microcarrier, cell / microcarrier, cell / mL culture system.
[0089] In the method for sampling cells cultured on a microcarrier, the microcarrier is the 3D FloTrix microcarrier (catalog number: CNF-F01T-50) available from Beijing CytoNiche Biotech Ltd. The sampling tube is specifically a 1.5 ml microcentrifuge tube.
[0090] In one embodiment, the weight of the microcarrier weighed in step (D1) is 5 mg; the sampling tube is a 1.5 ml microcentrifuge tube. The standard scale is a 0.1 mL scale. In the cell culture system, the weight of the microcarrier is 200 mg, the initial cell number in the culture is 2 million, and the medium of the culture system has a volume of 60 mL. Sampling is performed after 72 hours of cell culture.
[0091] Any of the above methods further comprise a three-dimensional microcarrier-based method for large-scale expansion of cells comprising the following steps: achieving large-scale expansion of cells on a three-dimensional microcarrier in a stirred bioreactor.
[0092] Stirred bioreactors may include, but are not limited to, semi-automatic, fully automatic, or integrated bioreactors. Specifically, stirred bioreactors may be 3D FloTrix miniSpin small-scale bioreactors or 3D FloTrix vivaSpin bioreactors. A single bioreactor or a combination of two bioreactors may be used.
[0093] The conditions under which cells are cultured in a bioreactor can be controlled according to cell growth. For example, the incubation pH may be 6.5 to 7.5, preferably 7.0 to 7.5, more preferably 7.2; the active pumping of CO2 may be about 3 to 10%, preferably about 5 to 8%, more preferably about 5; the temperature may be 30 to 40°C, preferably 37°C; the stirring speed may be 10 to 150 rpm, preferably 40 to 80 rpm; and the gas transfer frequency may be 1 to 40 ccm, more preferably about 5 to 20 ccm.
[0094] In an embodiment of the present invention, cells were inoculated onto a three-dimensional microcarrier and cultured for 6 days at a constant clockwise speed of 60 rpm in a 3D FloTrix miniSpin small-scale bioreactor, after which they were transferred to a 3D FloTrix vivaSpin bioreactor. The process parameters set for the 3D FloTrix vivaSpin bioreactor were controlled throughout the process with 5% CO2 active pumping of 12 cc / m and a temperature of 37°C. 800 mL of complete medium was actively pumped at a rate of 10 mL / min at T = 0 hours, 500 mL of liquid was actively pumped at a rate of 10 mL / min, and then 500 mL of fresh medium was pumped at 1 hour. At T = 96 hours, 500 mL of liquid was actively pumped at a rate of 10 mL / min, and then 50 3D TableTrix microcarriers resuspended in 500 mL of fresh medium were purified at a rate of 10 mL / min at T = 144 hours. The stirring speed for T = 0 to 12 hours and T = 144 to 156 hours was a variable speed with a constant speed cycle of 40 rpm for 5 minutes, 20 rpm for 20 minutes, and 60 rpm for the remainder of time.
[0095] In another embodiment of the present invention, cells were inoculated onto a three-dimensional microcarrier and then directly inoculated into a 3D FloTrix vivaSpin bioreactor. The process parameters set for the 3D FloTrix vivaSpin bioreactor were controlled throughout the process with 5% CO2 active pumping of 10 cc / m and a temperature of 37°C. 460 mL of complete medium was actively pumped at a rate of 10 mL / min at T = 0 hours, followed by 500 mL of liquid being actively pumped at a rate of 10 mL / min at T = 48 hours. Thereafter, every 24 hours, 500 mL of liquid was actively pumped at a rate of 10 mL / min, followed by 500 mL of fresh medium being actively pumped into the reactor at a rate of 10 mL / min, and pumped up to 120 hours. At T = 120 hours, 500 mL of liquid n was actively pumped at 10 mL / min, after which 40 tablets of 3D TableTrix microcarriers resuspended in 500 mL of fresh medium were actively pumped into the reactor at a rate of 10 mL / min. The stirring speed was a constant 60 rpm during T = 0 to 120 hours; during T = 120 to 136 hours, the stirring speed was variable in cycles of 60 rpm for 5 minutes and 20 rpm for 20 minutes; during T = 136 to 240 hours, the stirring speed was a constant 60 rpm (after 240 hours, the stirring mode was a constant 60 rpm).
[0096] Any of the above three-dimensional microcarriers may specifically refer to microcarrier beads having a porous structure, and the cells to be cultured therein are cultured on the three-dimensional microcarriers within a cell culture vessel (e.g., a cell culture flask, a well plate, or a bioreactor). In microcarrier culture, cells may be attached to the pores internally connected to the surface of the three-dimensional microcarrier, whereas the microcarrier may be suspended in the culture medium of the culture vessel by gentle stirring. Exemplary three-dimensional microcarriers include, but are not limited to, 3D TableTrix microcarriers, 3D FloTrix microcarriers, etc.
[0097] Any of the above cells is an adherent cell and, specifically, may be a stem cell. Stem cells include, but are not limited to, mesenchymal stem cells (MSCs), embryonic stem cells (ESCs), adipocyte stem cells (ADSCs), neural stem cells (NSCs), and induced pluripotent stem cells (iPSCs) from various tissue sources, and cells derived from stem cells, etc. Stem cells may be, in particular, mesenchymal stem cells. MSCs may specifically be adipose-derived MSCs or umbilical cord MSCs. Brief explanation of the drawing
[0098] Figure 1 shows a cell culture flask with an embedded impeller used in Example 1 of the present invention. Figure 2 shows the number of cells and the attachment efficiency gradually attached to the microcarrier by the rotary attachment method of cells and microcarriers in Example 1 of the present invention. Figure 3 is a graph showing the results of fluorescence staining after cell attachment by the method of Example 1 of the present invention. Figure 4 shows a diagram of microcarrier lysis observed under bright-field microscope and living cells observed under a fluorescence microscope in Example 2 of the present invention. Figure 5 shows the results of comparing the cell activity of the 3D microcarrier (3D FloTrix microcarrier) collected from the lysis solution in Example 2 of the present invention with the cell activity in the culture flask obtained by conventional trypsin treatment. Figure 6 shows that 5 mg of microcarrier reaches a scale exactly matching 0.1 mL on a 1.5 mL microcentrifuge tube in Example 3 of the present invention. Figure 7 shows pipetting by the suspension quantitative sampling method after natural sedimentation in Example 3 of the present invention This shows the state of 1 mL of suspension. A1 to A3 represent three replicas. Fig. 8 shows the state of 1 mL of suspension pipetted by the microcarrier quantitative sampling method after natural precipitation in Example 3 of the present invention. B1 to B3 represent three replicas. Fig. 9 shows the results of comparing the total number of cells obtained by the suspension quantitative sampling method and the microcarrier quantitative sampling method in Example 3 of the present invention with the actual situation. Fig. 10 shows the monitoring results of three-dimensional static recovered cells and control group cells in Example 4 of the present invention. Fig. 11 shows the proliferation of three-dimensional static recovered cells and control group cells in Example 4 of the present invention. Fig. 12 shows the monitoring results of the microstructure of three-dimensional static recovered cells in Example 4 of the present invention. Fig. 13 shows the cell monitoring results of the three-dimensional dynamic cell recovery method in Example 4 of the present invention.Fig. 14 shows cell proliferation of the three-dimensional dynamic cell recovery method in Example 4 of the present invention. Fig. 15 compares six cell recovery methods in Example 4 of the present invention. Fig. 16 shows the monitoring results of the three-dimensional static recovered cell microstructure in Example 4 of the present invention. Fig. 17 shows cell proliferation of the three-dimensional dynamic recovered cell microstructure in Example 4 of the present invention. Fig. 18 shows static on adipose-derived MSCs in Example 5 of the present invention. on site When inoculated by passage, cells are present only on a few microcarriers (bright spots), whereas, on site This shows that cells are present in all microcarriers on the 4th day after subculture. Fig. 19 shows that in Example 5 of the present invention, the microcarrier is static on umbilical cord MSCs. on site On the second day after inoculation by the passage method, while there are many cells (bright spots) only in a few microcarriers, on site This shows that cells are present in all cells on the 4th day after subculture. Fig. 20 shows the static by the conventional post-digestion subculture method (240m) in Example 5 of the present invention. on site This shows that there is no significant difference (p=0.32) between the cell count obtained after culturing adipose-derived mesenchymal stem cells by the passage method and the cell count increasing from 500,000 at the time of inoculation to 2.1 million. Figure 21 shows that in Example 5 of the present invention, the cell count increased from 300,000 at the time of inoculation to 1.9 million after culturing umbilical cord MSCs by the static in situ passage method. Figure 22 shows that in Example 5 of the present invention, while only a small number of microcarriers had many cells (bright spots) on them on the 2nd day after all microcarriers were inoculated with adipose-derived MSCs by the dynamic passage method, cells were present on the 5th day after passage. Figure 23 shows dynamic on umbilical cord MSCs in Example 5 of the present invention on siteThis shows that when inoculated by passage, there are many cells (bright spots) in only a few microcarriers, whereas on the 5th day after passage culture, cells are present in all microcarriers. Fig. 24 shows that adipose-derived MSCs in Example 5 of the present invention can grow and expand from only 2 million cells on a seed microcarrier initially to 50 million cells after 5 days of culture by dynamic in situ passage. Fig. 25 shows that umbilical cord MSCs in Example 5 of the present invention can grow and expand from only 1 million cells on a seed microcarrier initially to 15.2 million cells after 7 days of culture by dynamic in situ passage. Fig. 26 shows on a microcarrier after different cryopreservation times in Example 6 of the present invention on siteThis shows a graph of the recovery results of cryopreserved HEK293 cells. Fig. 27 is a graph showing the ratio of living cells before cryopreservation to cells recovered after cryopreservation for HEK293 cells on a microcarrier in Example 6 of the present invention. Fig. 28 shows a histogram of the number of HEK293 cells on 3D FloTrix microcarriers and competitor microcarriers (GE Cytodex) after cryopreservation and recovery in Example 6 of the present invention. Fig. 29 shows a graph of the in situ recovery results of cryopreserved AD-MSCs on microcarriers after different cryopreservation times in Example 6 of the present invention. Fig. 30 compares the activity of AD-MSCs before and after cryopreservation in Example 6 of the present invention. Fig. 31 shows statistics on the number of AD-MSCs before and after cryopreservation and the cell recovery rate after cryopreservation in Example 6 of the present invention. Fig. 32 shows the statistical results regarding the growth of the number of cells in the first part of Example 7 of the present invention. Figure 33 shows the automated bioreactor (3D vivaSPIN V1, Beijing CytoNiche Biotech Ltd.) used in the first part of Example 7 of the present invention. Figure 34 shows the results of cell activity in the first part of Example 7 of the present invention. Figure 35 shows the statistical results regarding the growth of the number of cells in the second part of Example 7 of the present invention. Figure 36 shows the results of cell activity in the second part of Example 7 of the present invention. Specific details for implementing the invention
[0099] The following examples facilitate a better understanding of the invention but do not limit the invention. The experimental methods of the following examples were all routine methods unless otherwise specified. Unless otherwise specified, all test substances used in the following examples were purchased from a routine biochemical reagent store. The quantitative tests in the following examples were set up as three replicate experiments, and the average value was taken as the result.
[0100] Example 1: 3D microcarrier cell attachment culture method
[0101] The microcarrier used in the example was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. under catalog number CNF-F01T-50.
[0102] I. Method for attaching three-dimensional microcarrier cells using stirrer rotation attachment;
[0103] 1. Preparation of microcarriers: 200 mg of microcarrier powder was weighed for UV sterilization and poured into a sterile cell culture flask equipped with an impeller (see Fig. 1). Three groups were prepared.
[0104] 2. Cell preparation: Prepare an adipose-derived MSC suspension in advance and 5 x 10 6 The cells were resuspended in 60 mL of complete medium for later use. Three groups were prepared.
[0105] 3. Cell Inoculation: The above cell suspension was mixed in a cell culture flask equipped with an impeller and thoroughly mixed with 200 mg of microcarrier;
[0106] 4. Cell Attachment: Place a cell culture flask equipped with an impeller on a low-speed stirrer, place it in a 37°C, 5% CO2 incubator, and stir at 80 rpm to allow the cells to rotate and attach to the microcarrier.
[0107] 5. Field calculation to obtain adhesion rate:
[0108] a. Microcarrier collection: After stirring for 2, 4, and 6 hours, respectively, the microcarriers of the three groups were mixed with the cell suspension and collected through a 70 μm cell sieve. Cells not attached to the microcarriers were washed once with PBS. Subsequently, the microcarrier suspensions containing cells were centrifuged at 1500 rpm for 2 minutes, and the supernatant was discarded.
[0109] b. Cell counting: 200 mg of microcarrier was added to 50 mL of 0.1% crystal violet solution (0.1 g crystal violet, 2.1 g citric acid, 20 μL Tween-80, 100 ml deionized water) at 37°C for 2 hours. Cells were counted using a cell counter up to 5 hours, and the attachment rate was calculated based on the number of initial inoculations after conversion.
[0110] c. Analysis of Results: Figure 2 shows that as stirring time increases, cells can gradually attach to the microcarrier by rotational attachment. The attachment efficiency reached 67% at 2 hours of stirring, 81% at 4 hours, and 92% at 6 hours.
[0111] II. Method for 3D Microcarrier Cell Attachment Using Small Amount of High-Density Swelling Attachment
[0112] 1. Preparation of microcarrier: 20 mg of microcarrier powder was measured for UV sterilization for later use.
[0113] 2. Cell preparation: A lipid-derived MSC suspension was prepared in advance at a density of 2.5 x 10⁶ cells / mL, and 200 μL was prepared for every 20 mg of 3D microcarrier.
[0114] 3. Cell inoculation: 200 μL of cell suspension was pipetteed and added dropwise to 20 mg of microcarrier to ensure the cell suspension was well mixed with the microcarrier.
[0115] 4. Cell Attachment: Microcarriers well mixed with the cell suspension were placed in a 37°C, 5% CO2 incubator for 2 hours to allow the cells to attach to the microcarriers.
[0116] 5. Cell culture: After the cells attach, add 3 mL of complete medium and incubate the cells in a 5% CO2 incubator at 37°C for 24 hours, then observe.
[0117] 6. Control experiment: Steps 3 to 5 adopted the small volume high-density attachment method of the present invention; additionally, a control group experimental group was prepared for the general attachment method (large volume low density). Specifically, 200 μL of cell suspension was mixed into 3 mL of complete medium, and 20 mg of microcarrier was directly added, and the cells were observed after 24 hours.
[0118] 7. Cell Observation:
[0119] 1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0120] 2) 50 to 100 μL of a three-dimensional microcarrier suspension containing cells was added to a 96-well plate.
[0121] 3) The supernatant was removed as much as possible, and the wells were washed once with PBS. After 2 minutes, the PBS was removed as much as possible, and 100 μL of the staining solution prepared according to the kit instructions was added to each well for staining. The wells were stained at room temperature for 20–30 minutes, and after blocking light, observed under a fluorescence microscope. The results are shown in Figure 3.
[0122] As shown in Fig. 3, living cells were stained with a staining solution and observed to emit light due to fluorescence, and the glowing cells were living cells. The figure shows that in the case of the large-volume low-density attachment method, a small number of cells were attached to the surface of the microcarrier and mainly to the surface of the microcarrier, whereas the small-volume high-density attachment method can attach a large number of cells. Since the microcarrier and cells exist not only on the surface of the microcarrier but also in the pores of the porous microcarrier, it was shown that the small-volume high-density attachment method of the present invention can be more effective and superior for attaching cells to the microcarrier. It utilizes a large area of the porous microcarrier.
[0123] Example 2: Method for harvesting cells on a three-dimensional microcarrier
[0124] The microcarrier used in the example was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. under catalog number CNF-F01T-50.
[0125] 1. Dissolution solution formulation: 0.1% (mass percent) collagenase (Sigma-Aldrich (Shanghai) Trading Co., Ltd., CC0130), 0.1% (mass percent) EDTA (Beijing Solarbio Science & Technology Co., Ltd., E1170), 0.05% (mass percent) trypsin (M&C Gene Technology (Beijing) Ltd., CC017); Termination solution: Complete medium;
[0126] 2. Transfer 20 mg of a 3D microcarrier containing lipid-derived MSCs from a culture dish to a centrifuge tube, centrifuge at 400 xg for 2 minutes, pipette the supernatant, add an appropriate amount of PBS, and then gently shake. Hold the container in your hand for 20–30 seconds, pipette the supernatant as much as possible, and repeat the PBS wash once.
[0127] 3. Add 3 mL of lysis solution and culture the cells in a cell incubator at 37°C for 30 minutes, and during this period, gently blow several times every 10 minutes with a 1 mL pipette.
[0128] 4. After 30 minutes, the microcarrier was completely dissolved, and 3 mL of the total medium was added to terminate the dissolution process.
[0129] 5. Centrifugation was performed at 200xg for 5 minutes, the supernatant was discarded, and the cells were resuspended as needed for subsequent application.
[0130] 6. Cell detection method:
[0131] (1) In situ Calcein-AM / PI staining method for living cells:
[0132] 1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0133] 2) 20 mg of a 3D microcarrier suspension containing cells was added to a centrifuge tube. It was centrifuged at 400xg for 2 minutes.
[0134] 3) Remove as much of the supernatant as possible, wash once with PBS, and after 2 minutes, remove as much of the PBS as possible and add 100 μL of the staining solution prepared according to the kit instructions for staining. Stain at room temperature for 20–30 minutes, protect from light, and centrifuge the tube at 400xg for 2 minutes.
[0135] 4) The supernatant was discarded, 3 mL of lysis solution was added, and the lysis of the microcarrier was observed using an optical microscope, and living cells were observed using a fluorescence microscope at 0, 10, and 30 minutes. The results are shown in Figure 4.
[0136] As can be seen in Figure 4, the microcarrier is observed in the bright field of an optical microscope, where it gradually dissolves and disappears over time, leaving only the cells. Observation of the stained cells under a fluorescence microscope revealed that as the lysis solution dissolved the microcarrier, the cells separated from the microcarrier and became single cells, while the number of dead cells did not increase and the cells maintained their activity. This indicates that the dissolution of the microcarrier does not affect the activity of the microcarrier, and cells can be harvested from the microcarrier.
[0137] (2) Analysis method for determining the rate of apoptosis by flow cytometry:
[0138] 1) Cell Collection: 20 mg of a 3D microcarrier suspension containing cells was centrifuged at 400 x g for 2 minutes, and the supernatant was discarded. 3 mL of 0.1% Collagenase Type IV solution (1 g of Collagenase Type IV (Gibco, 17104019) dissolved in 1 L of PBS) was added, and the solution was incubated in a cell incubator at 37°C for 30 minutes, followed by centrifugation at 400 x g for 5 minutes, after which the supernatant was discarded. For the harvesting of 2D cells, the conventional trypsin digestion method was used; that is, the medium in the cell culture flask was discarded, and an appropriate amount of PBS was added to wash the cells twice with an appropriate amount of 0.25%. Trypsin solution was added, and the cells were incubated at 37°C for 2 minutes or until they detached from the flask. After adding an equal amount of complete medium to terminate the process, the suspension was removed into a centrifuge tube, centrifuged at 400 lb for 5 minutes, and the supernatant was discarded.
[0139] 2) Cell washing: Cells were resuspended once in PBS pre-cooled at 4°C, centrifuged at 400 xg for 5 minutes, and then washed.
[0140] 3) Cell Staining: Cells were stained using the Annexin V-FITC / PI Apoptosis Detection Kit (HaiGene Biotech Co., Ltd, S0185). Specifically, 300 μL of Binding Buffer was added, followed by 5 μL of Annexin V-FITC, mixed, and incubated for 15 minutes at room temperature protected from light; then, 5 μL of PI was added for staining for 5 minutes. 200 μL of Binding Buffer was added.
[0141] 4) Cell Flow Cytometry: Flow cytometry of stained cells was performed using a BD FACSAria II flow cytometer, and a cell classification analysis report was generated by the instrument.
[0142] 5) Interpretation of the cell flow cytometry report:
[0143] A) Annexin-V negative - PI negative represents normal cells, i.e., the ratio of cells to living cells, in the bottom-left group of the 4-frame cell classification diagram.
[0144] B) Annexin-V positive - PI negative represents cells in the early stages of apoptosis, i.e., the bottom right group of the 4-frame cell classification diagram, and the cell ratio is the proportion of cells in the early stages of apoptosis.
[0145] C) Annexin-V positive - PI positive represents cells in the late apoptotic stage or necrotic cells, i.e., the top right group in the 4-frame cell classification diagram, and the cell ratio is the proportion of cells in the late apoptotic stage.
[0146] As can be seen from the results in Figure 5, the activity of cells harvested from 3D microcarriers (3D FloTrix microcarriers) by the lysis solution was similar to or slightly higher than the activity of cells obtained in a culture flask by conventional trypsin degradation. This indicates that the present invention is effective in harvesting highly active cells by targeting microcarriers with a lysis solution and harvesting cells on the microcarriers.
[0147] Example 3: Method for sampling and counting cells cultured on a microcarrier
[0148] The microcarrier used in the example was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. under catalog number CNF-F01T-50.
[0149] The cells included in the example were mesenchymal stem cells.
[0150] Design Concept: In the present invention, a standard balance is calibrated by measuring the volume of a microcarrier of a specific weight. When using microcarriers in cell culture, the volume of microcarrier to be sampled (unrelated to the volume of the culture medium) required to reach the reference scale is counted, and the total number is obtained by converting it to the entire culture system. This method is referred to as the quantitative sampling method for microcarriers.
[0151] Examples of specific protocols:
[0152] 1. 5 mg of microcarrier was added to a 1.5 mL sampling tube (microcentrifuge tube), dissolved in 1 mL of PBS, completely immersed and swollen, and then centrifuged at 1500 rpm for 2 minutes to correct the volume occupied by the microcarrier in the sampling tube. In this example, it was found that 5 mg of microcarrier precipitated to a scale exactly matching 0.1 mL in the 1.5 mL sampling tube (Fig. 6).
[0153] 2. 2 million cells were resuspended in 60 mL of medium, 200 mg of microcarrier was added, and incubated at 37°C in a 5% CO2 incubator.
[0154] 3. After 72 hours, two sampling methods were used as follows.
[0155] (a) The microcarrier was suspended as uniformly as possible in 60 mL of medium by shaking the culture vessel, and 1 mL of the suspension was pipetted as quickly as possible and added to a 1.5 mL sampling tube. A total of 3 tubes were pipetted (see Fig. 7). This was the quantitative sampling method for the suspension.
[0156] (b) The culture vessel was shaken to suspend the microcarrier in the medium, and the suspension was pipetted into a 1.5 mL sampling tube. After waiting a few minutes for the microcarrier to stabilize, it was observed whether the volume of the microcarrier reached the standard scale corrected in Step 1. In this example, a standard scale of 0.1 mL was used (corresponding to 5 mg of microcarrier, Fig. 6). If not, the suspension was continued to be pipetted until the scale was reached, and if it exceeded the limit, the excess microcarrier was removed from the sampling tube. A total of three tubes were pipetted (see Fig. 8). This was a quantitative sampling method for the microcarrier.
[0157] 4. The above sampling tube was centrifuged at 1500 rpm for 2 minutes, and the supernatant was discarded. Cell digestion solution was added to digest the cells from the microcarrier, and the cells were counted. The total number of cells in the culture system was estimated according to the formula based on the sampling method.
[0158] (a) Quantitative sampling method for suspension: Number of cells in 1 mL of suspension sample × Total suspension volume of the culture system (i.e., 60 mL) = Total number of cells.
[0159] The results are as shown in Table 1.
[0160]
[0161] (b) Quantitative sampling method for microcarriers: Number of cells in a 5 mg microcarrier (i.e., 0.1 mL microcarrier volume) sample × Total weight of microcarriers in the culture system (i.e., 200 mg) = Total number of cells.
[0162] The results are as shown in Table 2.
[0163]
[0164] 5. In a culture system with 200 mg of microcarrier and 60 mL of medium, all microcarrier suspension was removed, centrifuged at 1500 rpm for 2 minutes, the supernatant was discarded, and the cells were lysed from the microcarrier by adding cell lysis solution and the actual total number. The results were compared with the sampling count data from step 4.
[0165] The results are shown in Figure 9. The results show that the three samples of the microcarrier quantitative sampling method are more reproducible (less variance) and closer to the actual total.
[0166] Example 4: 3D Microcarrier-Based Cell Recovery Method
[0167] The microcarrier used in the example was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. under catalog number CNF-F01T-50.
[0168] The adipose-derived mesenchymal stem cell medium used in the examples was human mesenchymal stem cell medium (Viraltherapy Technologies Co., Ltd., Catalog No.: M001).
[0169] (I) 3D Microcarrier-Based Cell Recovery and Static Culture
[0170] I. Recovery and Static Culture of Adipose-Derived Mesenchymal Stem Cells
[0171] 1. Preparation of Static Culture Vessels and Microcarriers
[0172] Sterilized and dried microcarriers were placed in culture vessels. Available culture vessels included non-adhesive well plates and Petri dishes. An appropriate size should be selected based on the number of cells to be recovered, and care must be taken to tighten the vessel according to the environment required by the cells. The necessary microcarriers were placed aseptically into the selected culture vessels and kept dry at room temperature until inoculation was complete. For the experiment, one tablet (20 mg) of microcarrier was used in a non-adhesive 6-well plate.
[0173] 2. Recovery of cryopreserved cells
[0174] Cryopreserved fat-derived MSCs were collected and rapidly thawed in a 37°C water bath. They were rapidly transferred to an ultra-clean bench for subsequent routine recovery operations when ice was not present.
[0175] 3. Transfer of thawed cryopreserved cells
[0176] After the completion of Step 2, the thawed cells are washed and centrifuged to remove the supernatant, and the cells are resuspended in culture medium to a cell concentration preferably of 5 to 500 x 10⁻⁶ 5 A cell suspension with cells / mL was obtained. In the experiment, the cell concentration in the suspension was 1×10⁻¹⁰ 6 It was cells / mL.
[0177] 4. Vaccination
[0178] After completing Step 3, the cell suspension is 5 to 100 x 10 3 It was inoculated into 6-well plates containing the microcarrier prepared in Step 1 at a cell-to-microcarrier ratio of cells / mg and a 100-to-100-to-microcarrier ratio. In the 400μL:20mg experiment, 200μL of cell suspension (total 2×10 5 Cells were inoculated into the 6-well plate prepared in Step 1.
[0179] 5. Incubation
[0180] Although 20 to 240 minutes of incubation were required after the completion of Step 4, it is necessary to maintain an appropriate environment throughout the entire incubation process by paying attention to conditions such as temperature, humidity, sterility, and gas. Normal cell culture was sufficient. If the incubator does not have a humidity setting, some sterile wetting agents (PBS, culture medium, distilled water, and other liquids that provide a humid environment but do not affect or benefit the cells) can be manually added around the inoculated microcarriers. When culturing in small dishes, the small dishes can be placed in a larger container, and a wet box can be created around the small dishes in the larger container, similar to a well plate. In the experiment, 6-well plates were selected to be incubated in a CO2 incubator at 37°C for 2 hours, and 2 ml of PBS was added between the 6-well plates.
[0181] 6. Replenishment of culture medium
[0182] After completing Step 5, the replenishment volume was selected based on the number of inoculated cells, the medium exchange cycle, and the type of medium. 1 ml of serum medium was generally sufficient for 620,000 cells per day. In the experiment, 8 ml of medium was replenished.
[0183] 7. Culture and Recovery
[0184] After the completion of Step 6, the recovered cells were placed in a suitable culture environment for subsequent cell recovery and culture. In the experiment, 6-well plates were placed in a 37°C CO2 incubator for culture.
[0185] 8. Monitoring
[0186] Cell culture time, medium replenishment period, and cell status detection period can be set according to the needs of the experiment. Cell status indicators consisted of medium color, microcarrier status, cell staining analysis, and cell lysis count. In the experiment, cells were cultured for a total of 5 days, and the medium was replenished on the 4th day. Cell detection using the kit was performed on the 1st day. Cell counting was performed on the 1st and 4th days after inoculation (Step 10) and on the 5th day (Step 11).
[0187] 9. Fresh cell control group
[0188] (1) Cryopreserved lipid-derived MSCs were collected and rapidly thawed in a 37°C water bath. When ice was not present, they were rapidly transferred to an ultra-clean bench for subsequent routine retrieval. The thawed cells were washed and centrifuged to remove the supernatant, and the cells were resuspended in culture medium to obtain a cell suspension. This suspension was then transferred to a T75 cell culture flask containing 15 mL of medium at a concentration of 15,000 cells / cm² 2 Inoculated at a density of . Cultured for 3 days to grow fully.
[0189] (2) After step (1) is completed, the matured cells are subjected to conventional cell digestion and centrifuged to remove the supernatant, preferably 5 to 500 x 10 5 It was used in a medium having a cell concentration of cells / mL. In the experiment, the cell concentration of the cell suspension was 1 x 10⁶ 6 It was cells / mL.
[0190] (3) After completing step (2), cells were inoculated into a 6-well plate containing a microcarrier through steps 4 to 8, and subsequent operations were carried out. Cell detection using the kit was performed on days 1 and 4 after inoculation (step 10), and cell counting was performed on day 5 (step 11).
[0191] 10. Cell Monitoring
[0192] (1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0193] (2) 50 to 100 μL of a microcarrier suspension containing cells was added to a 96-well plate;
[0194] (3) Remove as much of the supernatant as possible, add PBS and wash once, and after 2 minutes, remove as much of the PBS as possible. Then, add 100 μL of the staining solution prepared according to the kit instructions to each well and stain. Stain at room temperature for 20 to 30 minutes, block light, and observe with a fluorescence microscope.
[0195] The results are shown in Figure 10. The results show that cryopreserved adipose-derived MSCs recovered from microcarriers for static culture initially ranged from 1 to 2 cells per microcarrier sphere to a larger range of cells in all microcarriers after 4 days. Although adipose-derived MSCs can be recovered directly into microcarriers for static culture, there was almost no difference when comparing the number of cells in microspheres inoculated with recovered cells to the number of cells inoculated with fresh cells. Since cell growth is the same as when fresh cells are traditionally obtained from a culture flask and inoculated into microcarriers, the tedious process of recovering cells to a culture flask and then digesting them to obtain new cells to inoculate into microcarriers is not required.
[0196] 11. Cell counting to determine cell proliferation
[0197] On the 5th day of cell culture, cells were harvested according to the method described in the patent application "Method for harvesting cells on a three-dimensional microcarrier" (Chinese Patent Application No.: 201910101736.0) and counted using a cell counting plate.
[0198] The results are shown in Fig. 11. As a result, when adipose-derived mesenchymal stem cells were fixed and cultured on a microcarrier (recovery group) and recovered from 200,000 cells at the time of inoculation, the cell count increased to 5,027,000, and there was no significant difference from the cell count (p=0.42). (5,187,000) were obtained using the conventional post-digestion subculture method (fresh group).
[0199] II. Recovery and Static Culture of Adipose-Derived Mesenchymal Stem Cell Microcarriers
[0200] Cryopreserved lipid-derived MSC microcarriers were prepared according to the method described in the patent application "Method for in situ cell cryopreservation for three-dimensional microcarriers" (Chinese application number 201910097650.5).
[0201] 1. Preparation of Static Culture Vessels and Microcarriers
[0202] It is the same as Step 1 of Part I.
[0203] 2. Recovery of cryopreserved cells
[0204] Cryopreserved fat-derived MSC microcarriers (referred to as fat-derived MSC microstructures in the following description) were taken and rapidly thawed in a 37°C water bath. Since the microstructures could affect the observation of the thawing results, the cryogenic storage tubes had to be tilted and gently shaken during observation, and were rapidly transferred to an ultra-clean bench for subsequent routine resuscitation tasks when ice was unavailable.
[0205] 3. Transfer of thawed cryopreserved cells
[0206] After completing Step 2, the thawed cells were washed and centrifuged to remove the supernatant, and the cells were resuspended in culture medium to obtain a cell suspension. The cell concentration of the microstructure in the cell suspension is preferably 5 to 500 x 10⁵ cells / ml. However, if the actual microcarrier itself occupies a large volume or if supernatant removal is poor, a resuspended volume somewhat larger than expected may occur, and it may expand to obtain the necessary cells when accurate counting is required. While increasing the centrifugal force to remove the supernatant allows for pipetting as much of the supernatant as possible, the occupied volume of the microcarrier itself can be excluded and has almost no effect on subsequent experiments.
[0207] 4. Vaccination
[0208] After completing Step 3, 200 µl of cell suspension was inoculated into a 6-well plate containing the microcarrier prepared in Step 1.
[0209] 5. Incubation
[0210] It is the same as Step 5 of Part I.
[0211] 6. Medium replenishment
[0212] It is the same as Step 6 of Part I.
[0213] 7. Culture and Recovery
[0214] It is the same as Step 7 of Part I.
[0215] 8. Monitoring
[0216] It is the same as Step 8 of Part I.
[0217] 9. Cell Monitoring
[0218] It is the same as Step 10 of Part I.
[0219] The results are shown in Figure 12. The results show that cryopreserved adipose-derived MSC microtissues were recovered as new microcarriers in static culture. After recovery, only a few microcarriers in D1 had many cells (bright spots), which were the recovered microtissues, and the rest with fewer cells were new microcarriers. This indicates that cryopreserved microtissues can be recovered as new microcarriers for static culture.
[0220] (II) 3D Microcarrier-Based Cell Recovery and Dynamic Culture
[0221] I. Recovery and Dynamic Culture of Adipose-Derived Mesenchymal Stem Cells
[0222] 1. Preparation of dynamic culture vessels and microcarriers
[0223] An appropriate amount of microcarrier was placed in a cell culture flask equipped with an impeller or in another clean, sterile, endotoxin-free container capable of stirring and suspending the microcarrier. The microcarrier was resuspended by adding 0 to 50% (v / v) of the final culture medium and allowed to stand or be stirred for at least 0 hours (no time limit). In the experiment, 10 tablets of 200 mg microcarrier were added to a 125 ml cell culture flask with an impeller containing 10 ml of medium and left for 10 minutes.
[0224] 2. Recovery of cryopreserved cells
[0225] Cryopreserved fat-derived MSCs were collected and rapidly thawed in a 37°C water bath. They were rapidly transferred to an ultra-clean bench for subsequent routine recovery operations when ice was not present.
[0226] 3. Transfer of thawed cryopreserved cells
[0227] After completing Step 2, the thawed cells were washed and centrifuged to remove the supernatant, and the cells were resuspended in culture medium to obtain a cell suspension, with a resuspension volume of 5 to 500 x 10⁻⁶ 5 It is 1 to 100% (volume percentage) of the medium for the final culture system at a concentration of cells / mL. In the experiment, the cell concentration in the suspension was 1 x 10⁶ in a total of 2 mL. 6 It was cells / mL.
[0228] 4. Vaccination
[0229] After completing Step 3, the cell suspension was mixed into the cell culture flask equipped with an impeller prepared in Step 1 and mixed with a new microcarrier. The ratio of cells to the new microcarrier was 5 to 100 x 10 3 After mixing cells / mg of microcarrier to be inoculated, cell culture medium was added, and the ratio of microcarrier to medium was adjusted to 1 mg:1 to 1000 μL. In the experiment, 2 million recovered cells were inoculated into 200 mg of new microcarrier, and 60 mL of medium was added.
[0230] A cell culture flask equipped with an impeller was placed on a low-speed stirrer and placed in an incubator for stirring. Stirring could be performed by constant-speed stirring, variable-speed alternating stirring, or variable-speed cyclic stirring. The stirring direction could be clockwise, counterclockwise, or alternating stirring to transfer cells from a seed microcarrier to a new microcarrier. The stirring time was 0.1 to 100 hours, and the stirring speed was 1 to 200 rpm. In the experiment, the variable-speed cyclic clockwise stirring method and the constant-speed clockwise stirring method were compared, and three sets of experiments were set up as follows.
[0231] Group 1 (standing inoculation): A cell culture flask with an impeller was placed on a low-speed stirrer and placed in an incubator for 4 hours, followed by a variable-speed cycle until 24:00, and then a clockwise cycle at 40 rpm for 5 minutes and 20 rpm for 20 minutes at a constant speed (60 rpm) until 96:00.
[0232] Group 2 (intermittent inoculation): A cell culture flask with an impeller is placed on a low-speed stirrer and placed in an incubator, and then circulated at 40 rpm for 5 minutes and at 20 rpm for 20 minutes for 24 minutes, and stirred clockwise at a constant speed (60 rpm) for up to 96 hours.
[0233] Group 3 (constant speed inoculation): A cell culture flask with an impeller was placed on a low-speed stirrer and placed in an incubator at a constant clockwise speed (60 rpm) for up to 96 hours.
[0234] Each group was sampled at 4 hours for cell detection (step 6).
[0235] The culture continued.
[0236] After completing Step 4, culture was continued until Day 6 at a constant speed (60 rpm) while stirring clockwise. Samples were collected on Days 1, 2, 3, 4, 5, and 6 for cell counting (Step 7).
[0237] 6. Cell Monitoring
[0238] (1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0239] (2) A microcarrier suspension containing 50 to 100 μL of cells was added to a 96-well plate;
[0240] (3) Remove as much of the supernatant as possible, add PBS and wash once, and after 2 minutes, remove as much of the PBS as possible. Then, add 100 μL of the staining solution prepared according to the kit instructions to each well and stain. Stain at room temperature for 20 to 30 minutes, block light, and observe with a fluorescence microscope.
[0241] The results are shown in Fig. 13. The results show that various stirring methods and speed settings affected the cell distribution within the microcarrier during the recovery of cryopreserved lipid-derived MSCs from dynamic culture. Recovery promotes a uniform distribution of cells.
[0242] 7. Cell counting to determine cell proliferation
[0243] After varying the cell inoculation dates, cells were harvested according to the method described in the patent application "Method for harvesting cells on a three-dimensional microcarrier" (Chinese Patent Application No.: 201910101736.0) and counted using a cell counting plate.
[0244] The results are shown in Fig. 14. The results indicate that the cryopreserved cells recovered from the microcarrier proliferated from an initial 2 million to approximately 17.13 million after 3 days of culture. Just as there was no significant difference in cell numbers among these three rate adjustments (Group Steps 4, 1 to 3), this indicates that the recovery of lipid-derived MSCs cryopreserved on microcarriers for dynamic culture is not affected by the stirring speed for inoculation (an appropriate speed suitable for the cells), thereby demonstrating that the recovery and growth processes of the cells are not affected regardless of the stirring speed for inoculation.
[0245] Method Comparison
[0246] 3D Dynamic Recovery Cell Group: 3 groups of 4 steps.
[0247] 3D Dynamic Fresh Cell Group: (1) Cryopreserved lipid-derived MSCs were collected and rapidly thawed in a 37°C water bath. When ice was not present, they were rapidly transferred to an ultra-clean bench for subsequent routine retrieval. The thawed cells were washed and centrifuged to remove the supernatant, and the cells were resuspended in culture medium to obtain a cell suspension, which was then transferred to a T75 cell culture flask containing 15 mL of medium at a concentration of 15,000 cells / cm² 2 (2) After step (1) is completed, the mature cells are subjected to conventional cell digestion, centrifuged to remove the supernatant, and then preferably 5 to 500 x 10 5 It was used in a medium having a cell concentration of cells / mL. In the experiment, the cell concentration of the cell suspension was 1 x 10⁶ 6 cells / mL. (3) After completing step (2), the cell suspension was placed in a prepared cell culture flask equipped with an impeller, and the container and microcarrier were prepared according to step (II) 1 and mixed with the microcarrier. After mixing, cell culture medium was added, and the ratio of microcarrier to medium was adjusted to 1 mg:1 to 1,000 μL. In the experiment, 2 million new cells were inoculated into 200 mg of new microcarrier, and the medium was supplemented to 60 mL. The culture flask equipped with the impeller cells was placed on a low-speed stirrer and placed in an incubator while stirring constantly clockwise at 60 rpm, and samples were collected until Day 6. For cell counting, samples were collected on Day 1, Day 2, Day 3, Day 4, Day 5, and Day 6.
[0248] 3D static recovery cell group: 3D static recovery cell group in Step 1 of Part (I).
[0249] 3D static fresh cell group: 3D static fresh cell group in Step 1 of Part (I).
[0250] 2D Recovery Group: Cryopreserved lipid-derived MSCs were collected and rapidly thawed in a 37°C water bath. When ice was unavailable, they were rapidly transferred to an ultra-clean bench for subsequent routine recovery operations. The thawed cells were washed and centrifuged to remove the supernatant, and the cells were resuspended in culture medium to obtain a cell suspension. This suspension was seeded into a 6-well plate at a density of 100,000 cells / well, 4 mL of medium was added, and one well was taken for cell counting on days 1, 2, 3, and 4, respectively.
[0251] Two-dimensional passage group: T75 filled with MSCs was taken, fresh cells were lysed from T75 according to a conventional cell lysis method, the supernatant was removed by centrifugation, and the cells were resuspended in culture medium to obtain a cell suspension. The cells were inoculated into 6-well plates at a density of 100,000 cells / well, 4 mL of medium was added, and one well was taken for cell counting on days 1, 2, 3, and 4, respectively.
[0252] The result is as shown in Fig. 15.
[0253] Figure 15A shows that adipose-derived MSCs, after being recovered on a microcarrier and dynamically cultured, expanded from an initial 2 million recovered cells to 76.33 million after 6 days of culture. Adipose-derived MSCs were recovered to grow fully in culture flasks and then subcultured on a microcarrier for dynamic culture, expanding from an initial 2 million cells to 58.93 million cells after 6 days of culture. There was no significant difference between the two types of cells during the first 3 days; although subcultured cells grew faster than recovered cells on days 4 and 5, recovered cells were numerically more numerous than subcultured cells on day 6. Figure 15B shows a two-dimensional control of the corresponding cells, from which it can be seen that subcultured cells grew slower than recovered cells during the first 3 days, and by day 4, both groups of cells were limited by space and decreased. The numbers indicate that recovered cells grew more slowly. Figure 15C shows a comparison of proliferation times of recovered cells inoculated into static and dynamic cultures on a microcarrier. There was no significant difference between the two, but a subtle difference was that the retrieved static cells were slightly slower than the retrieved dynamic cells, suggesting that the retrieved cells are more suitable for moderate stirring speeds. Figure 15D shows that the subdivided cells are more resistant to shear forces and there is no significant difference between the two, indicating that overall, cryopreservation causes significant damage to the cells and requires some time for retrieval. Figures 15E and 15F both compared cells in dynamic and two-dimensional cultures; there was no significant difference during the first three days, while the two-dimensional culture showed a significant difference on the fourth day due to space limitations.
[0254] II. Recovery and Dynamic Culture of Adipose-Derived Mesenchymal Stem Cell Microcarriers
[0255] Cryopreserved lipid-derived MSC microcarriers were prepared according to the method described in the patent application "Method for in situ cell cryopreservation for three-dimensional microcarriers" (Chinese application number 201910097650.5).
[0256] 1. Preparation of dynamic culture vessels and microcarriers
[0257] An appropriate amount of microcarrier was placed in a cell culture flask equipped with an impeller or in another clean, sterile, endotoxin-free container capable of stirring and suspending the microcarrier. The microcarrier was resuspended by adding 0 to 50% (v / v) of the final culture medium and allowed to stand or be stirred for at least 0 hours (no time limit). In the experiment, 10 tablets of 200 mg microcarrier were added to a 125 ml cell culture flask with an impeller containing 10 ml of medium and left for 10 minutes.
[0258] 2. Recovery of cryopreserved microstructure
[0259] Cryopreserved lipid-derived MSC microcarriers (referred to as lipid-derived MSC microstructures in the following description) were taken and rapidly thawed in a 37°C water bath. Since the microstructures could affect the observation of the thawing results, the cryogenic storage tubes had to be tilted and gently shaken during observation, and were rapidly transferred to an ultra-clean bench for subsequent routine resuscitation tasks when ice was unavailable. 0.1 to 25 x 10⁶ per mg of frozen microstructure 6 There were cells, and the total number of cells ranged from 5 to 100 x 10 3 It was per mg of microcarrier for cells / inoculation. In the experiment, 0.25 x 10⁶ microtissues per mg 6 There were cells, and the total number of cells was 2 x 10 6 It was a cell.
[0260] 3. Transfer of thawed cryopreserved cells
[0261] After completing Step 2, the thawed cells were washed and centrifuged to remove the supernatant, and the cells were resuspended in culture medium to obtain a cell suspension, with the resuspension volume being 1 to 100% (volume percentage) of the medium, 5 to 500 x 10⁻⁶ 5Final culture system at a cells / mL concentration. In the experiment, the cell concentration in the suspension was 1 x 10⁶ at a total of 2 mL. 6 It was cells / mL.
[0262] 4. Vaccination
[0263] After the completion of Step 3, the above microstructure suspension was mixed into a cell culture flask equipped with an impeller prepared in Step 1 and mixed with a new microcarrier. The number of cells recovered on the microstructure ranged from 5 to 100 x 10⁶. 3 New microcarriers of cells / mg were mixed, and medium was added to adjust the microcarrier-to-medium ratio to 1 mg:1 to 1000 μL. In the experiment, 200 mg of new microcarriers was inoculated into 2 million recovered cells, and 60 mL of medium was added.
[0264] A cell culture flask equipped with an impeller was placed on a low-speed stirrer and placed in an incubator for stirring. Stirring could be performed by constant-speed stirring, variable-speed alternating stirring, or variable-speed circulating stirring, and the stirring direction could be clockwise, counterclockwise, or alternating stirring to perform the culture. The experiment was conducted at a constant clockwise speed of 60 rpm for 96 hours, followed by continuing at a constant clockwise speed of 60 rpm for 4 days. Samples were collected on the 4th day for cell detection (step 5) and cell counting (step 6).
[0265] 5. Cell Monitoring
[0266] (1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0267] (2) A microcarrier suspension containing 50 to 100 μL of cells was added to a 96-well plate;
[0268] (3) Remove as much of the supernatant as possible, add PBS and wash once, and after 2 minutes, remove as much of the PBS as possible. Then, add 100 μL of the staining solution prepared according to the kit instructions to each well and stain. Stain at room temperature for 20 to 30 minutes, block light, and observe with a fluorescence microscope.
[0269] The results are shown in Fig. 16. The results show that when cryopreserved lipid-derived MSC microcarriers are recovered to a new carrier, they gradually resume expansion from a smaller number of cells initially to a larger number of cells in each microcarrier sphere. This indicates that the cryopreserved microtissues are recovered directly to the new carrier.
[0270] 6. Cell counting to determine cell proliferation
[0271] After varying the cell inoculation dates, cells were harvested according to the method described in the patent application "Method for harvesting cells on a three-dimensional microcarrier" (Chinese Patent Application No.: 201910101736.0) and counted using a cell counting plate.
[0272] The results are shown in Figure 17. The results showed no significant difference between umbilical cord MSC microtissues cryopreserved after being recovered on a culture microcarrier and cells cryopreserved after being recovered and inoculated on a culture microcarrier, with a P value of 0.73. The microtissue group expanded to 2 million cells on the initial seed microcarrier and to 42.82 million cells after 4 days of culture, indicating that the microtissues can be recovered on a microcarrier after cryopreservation.
[0273] Example 5: 3D microcarrier cell culture base on site generational law
[0274] The microcarrier used in the example was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. under catalog number CNF-F01T-50.
[0275] (I) Static based on 3D microcarrier cell culture on site Keimyung University
[0276] Test cells: Adipose-derived MSCs and umbilical cord MSCs.
[0277] I. Static on site Subgeneration method
[0278] 1. Preparation of a new microcarrier
[0279] Sterilized and dried microcarriers were placed in a culture vessel. In the example, 20 mg of microcarriers were used in a 6-well plate.
[0280] 2. Preparation of Seed Microcarrier Suspension
[0281] The seed microcarrier was a microcarrier cultured with test cells. The seed microcarrier was cultured according to Patent Application No. 201910098003.6 (Cell attachment culture method for three-dimensional microcarriers). Microcarriers having a cell density of 10,000 to 1,000,000 cells / mg were used as seed microcarriers, and the seed microcarriers were resuspended in cell culture medium at a concentration of 0.1 to 50 mg / mL (i.e., 0.5 to 25 million cells / mL volume).
[0282] Here, for fat-derived MSCs: a cell density of 500,000 cells / mg microcarrier and a resuspension density of 5mg / mL; for umbilical cord MSCs: a cell density of 120,000 cells / mg microcarrier and a resuspension density of 15mg / mL.
[0283] 3. Vaccination
[0284] After thoroughly mixing the seed microcarrier suspension prepared in Step 2 above, an appropriate amount of the seed microcarrier suspension was pipetted dropwise into a 6-well plate prepared in Step 1 containing 20 mg of new microcarrier, and the seed microcarrier suspension was thoroughly mixed with the new microcarrier. The ratio of seed microcarrier to new microcarrier was 0.0002 to 200 mg seed microcarrier / mg new microcarrier. The mixed microcarrier was incubated in an incubator for an appropriate time, which could be 0.5 to 24 hours, specifically 2 hours or 24 hours; and the cells on the seed microcarrier were transferred to the new microcarrier.
[0285] Here, for fat-derived MSCs: 1 mg of seed microcarrier was inoculated into 20 mg of new microcarriers; for umbilical cord MSCs: 3 mg of seed microcarrier suspension inoculated into 20 mg of microcarriers; both groups of cells were incubated in an incubator for 2 hours.
[0286] 4. Culture: After culture, add cell culture medium according to conventional cell culture methods to continue cell culture, and then... on site The lineage was completed.
[0287] II. Control Experiment
[0288] For the control experiment, cells were lysed and then inoculated onto a microcarrier for passage. That is, cells on a seed microcarrier were lysed and collected (according to Patent Application 201910101736.0, "Method for harvesting cells on a three-dimensional microcarrier"). The cells were resuspended in a cell-alone suspension mixed with 20 mg of microcarrier at the same cell concentration and inoculation volume as in step 3, cultured for 2 hours, and then added to a cell culture medium for further culture.
[0289] III. Results
[0290] 1. Cell observation
[0291] (1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0292] (2) 50 to 100 μL of a microcarrier suspension containing cells was added to a 96-well plate;
[0293] (3) Remove as much of the supernatant as possible, add PBS and wash once, and after 2 minutes, remove as much of the PBS as possible. Then, add 100 μL of the staining solution prepared according to the kit instructions to each well and stain. Stain at room temperature for 20 to 30 minutes, block light, and observe with a fluorescence microscope.
[0294] Result Analysis:
[0295] Figure 18 shows static on fat-derived MSCs on site When inoculated by the subculturing method, cells were present in only a few microcarriers (highlighted), showing that the seed microcarriers and the remaining ones without cells were new microcarriers. On the 4th day after subculturing in situ, cells were present in all microcarriers, indicating that cells on the seed microcarriers could transfer to new microcarriers and proliferate.
[0296] Fig. 19 is static on site It shows that on the 2nd day after inoculation by passage, only a small number of microcarriers had many cells (bright spots), which are seed microcarriers and the others with almost no cells are new microcarriers, whereas Day 4 on site After subculture, cells were present in all microcarriers, indicating that cells from the seed microcarrier can transfer to new microcarriers and proliferate.
[0297] 2. Cell count to determine whether the cells have completed passage.
[0298] This is performed according to the patent application "Method for harvesting cells on a three-dimensional microcarrier" (Application No. 201910101736.0).
[0299] After 4 days of culture, 20 mg of cell growth microcarriers were transferred from the culture well plate to a centrifuge tube, centrifuged at 400 xg for 2 minutes, the supernatant was pipetted, an appropriate amount of PBS was added, and the mixture was gently shaken. The supernatant was pipetted as much as possible while holding the container for 20–30 seconds, and the PBS wash was repeated once. 3 mL of lysis solution (lysis solution formulation: 0.1% collagenase, 0.1% ethylenediaminetetraacetic acid, 0.05% trypsin; % indicated g / 100 mL) was added, and the mixture was incubated in an incubator for 30 minutes, during which time the cells were gently blown several times with a 1 mL pipette every 10 minutes. After 30 minutes, the microcarriers were completely lysed, and 3 mL of total medium was added to terminate the lysis process. The tube was centrifuged at 200 xg for 5 minutes, the supernatant was discarded, the cells were resuspended, and counted using a cell counting plate.
[0300] Result Analysis:
[0301] Figure 20 shows that the number of adipose-derived mesenchymal stem cells, which was 500,000 at the time of inoculation, was static on site The number of cells increased to 2.1 million by passage, showing no significant difference from the number of cells obtained by the conventional post-digestion passage method (2.4 million) (p=0.32). Figure 21 shows the static on site It shows that the number of umbilical cord MSCs cultured by passage increased from 300,000 at the time of inoculation to 1.9 million cells, indicating that the cells proliferated and expanded.
[0302] (II) Dynamic based on 3D microcarrier cell culture on site Subculture
[0303] Test cells: Adipose-derived MSCs and umbilical cord MSCs.
[0304] I. Dynamic on site Subgeneration method
[0305] 1. Preparation of a new microcarrier suspension: 200 mg of new microcarrier powder was weighed and poured into a cell culture flask with an internal impeller (Bellco Glass, USA; Catalog No.: 1965-61001, schematic diagram shown in Fig. 1). Cell culture medium was added at a ratio of 1 to 2000 μL:1 mg microcarrier and left to stand or stirred for at least 0 hours (excluding 0 hours, no time limit).
[0306] Here, for adipose-derived mesenchymal stem cells: 20 ml of cell culture medium was added to 200 mg of new microcarrier and left for 14 hours. For umbilical cord MSCs: 10 ml of cell culture medium was added to 100 mg of new microcarrier and left for 14 hours.
[0307] 2. Preparation of Seed Microcarrier Suspension
[0308] The seed microcarrier was a microcarrier cultured with test cells. The seed microcarrier was cultured according to Patent Application No. 201910098003.6 (method for cell attachment culture for three-dimensional microcarriers). Microcarriers having a cell density of 10,000-1,000,000 cells / mg (e.g., 100,000-500,000 cells / mg) were used as seed microcarriers, and the seed microcarriers were resuspended at 0.1-50 mg / mL (i.e., 250 million cell dose).
[0309] Here, for adipose-derived MSCs: a seed microcarrier with a cell density of 500,000 / mg and a resuspension density of 1mg / mL. For umbilical cord MSCs: a seed microcarrier with a cell density of 150,000 / mg and a resuspension density of 1mg / mL.
[0310] 3. Vaccination
[0311] The seed microcarrier suspension prepared in Step 2 above is mixed into a cell culture flask equipped with an impeller in Step 1 and thoroughly mixed with a new microcarrier suspension; the ratio of seed microcarrier to new microcarrier is 0.0002 to 200 mg seed microcarrier / mg new microcarrier; and cell medium is added to adjust the ratio of microcarrier to culture medium to 1 mg:1-1000 μL.
[0312] Here, for adipose-derived MSCs: 4 mg of seed microcarrier (total 2 million cells) was used to inoculate 200 mg of new microcarriers, and 60 mL of cell culture medium was added. For umbilical cord MSCs: 6.7 mg of seed microcarrier (total 1 million cells) was used to inoculate 100 mg of new microcarriers, and 60 mL of cell culture medium was added.
[0313] A cell culture flask equipped with an impeller was placed on a low-speed stirrer (3D FloTrix miniSpin low-speed stirrer, Beijing CytoNiche Biotech Ltd., catalog number: 3D FTmS-2-2) and placed in an incubator for stirring. Stirring could be performed by constant-speed stirring, variable-speed alternating stirring, or variable-speed circulating stirring, and the stirring direction could be clockwise, counterclockwise, or alternating stirring to move cells from a seed microcarrier to a new microcarrier, and the stirring time was 0.1 to 100 hours.
[0314] Here, for the two MSCs, a variable speed cyclic clockwise stirring method was used in a cycle for a total of 24 hours, specifically 60 rpm for 5 minutes and 20 rpm for 20 minutes.
[0315] 4. Culture
[0316] After inoculation, culture can be continued while stirring until the expansion effect is achieved.
[0317] II. Control Experiment
[0318] A control experiment was performed by digesting lipid-derived MSCs and inoculating them onto a microcarrier for subculturing. Specifically, cells on a seed microcarrier were digested and collected (Patent Application 201910101736.0, "A method for Harvesting cells on three-dimensional microcarrier"), and then resuspended in a cell-specific suspension. Two million cells were resuspended in 4 mL, 200 mg of new microcarrier was inoculated into a cell culture flask equipped with an impeller, and 60 mL of cell culture medium was added. The cell culture flask equipped with an impeller was placed on a low-speed stirrer (3D FloTrix miniSpin low-speed stirrer, Beijing CytoNiche Biotech Ltd., Catalog No.: 3 FTmS-2-2) and placed in an incubator for 24 hours. Specifically, after heating at 60 rpm for 5 minutes and at 20 rpm for 20 minutes, stirring culture was continued until an expansion effect was obtained.
[0319] III. Results
[0320] 1. Cell Observation:
[0321] (1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0322] (2) 50 to 100 μL of a microcarrier suspension containing cells was added to a 96-well plate;
[0323] (3) Remove as much of the supernatant as possible, add PBS and wash once, and after 2 minutes, remove as much of the PBS as possible. Then, add 100 μL of the staining solution prepared according to the kit instructions to each well and stain. Stain at room temperature for 20 to 30 minutes, block light, and observe with a fluorescence microscope.
[0324] Result Analysis:
[0325] Fig. 22 is dynamic on siteOn day 2 after inoculating adipose-derived MSCs by passage, as can be seen in the fluorescence image (bright dot) of the seed microcarrier, only a few microcarriers show a large number of cells. However, in brightfield, there were other microcarriers, and it was clear that the one with almost no cells was a new microcarrier, proving that some cells were transferred to the new microcarrier by in situ passage and that cells were present on day 5 after in situ passage. For all microcarriers, this indicates that the cells transferred to the new microcarrier proliferated and expanded. Figure 23 shows dynamics in umbilical cord MSCs. on site As can be seen in the fluorescence image of the seed microcarrier when inoculated by the passage method, only a few microcarriers show many cells (bright spots). In bright field, it was clear that there were other microcarriers and that the other microcarriers without cells were new microcarriers, and on the 5th day after in situ passage culture, cells were present in all microcarriers, indicating that new microcarriers and cells from seed microcarriers capable of proliferation and expansion can be transferred to the next.
[0326] 2. Cell count to determine whether the cells have completed passage.
[0327] This is performed according to the patent application "Method for harvesting cells on a three-dimensional microcarrier" (Application No. 201910101736.0).
[0328] On a different day after inoculation, 3 mL of the microcarrier suspension was transferred from the flask to a centrifuge tube and centrifuged at 400xg for 2 minutes. The supernatant was pipetted, an appropriate amount of PBS was added, and the mixture was gently shaken by hand for 20 to 30 seconds. The supernatant was pipetted as much as possible, and the PBS wash was repeated once; 3 mL of lysis solution (lysis solution formulation: 0.1% collagenase, 0.1% ethylenediaminetetraacetic acid, 0.05% trypsin; % indicated g / 100 mL) was added, and the mixture was incubated in a 37°C incubator for 30 minutes. Cells were gently blown in several times every 10 minutes using a 1 mL pipette. After 30 minutes, the microcarrier was completely lysed, and 3 mL of total medium was added to terminate the lysis process. The tube was centrifuged at 200xg for 5 minutes, the supernatant was discarded, and the cells were resuspended according to the requirements of subsequent application and counted through a cell counter.
[0329] Result Analysis:
[0330] Figure 24 shows that the number of cells obtained from adipose-derived MSCs after 5 days of culture on a seed microcarrier initially containing only 2 million cells was 59.77 million, which is not significantly different from the number of cells obtained at 59.77 million. on site It shows that growth and expansion can be achieved by passage. By the conventional post-digestion passage method (51.4 million) (p=0.14). Fig. 25 shows umbilical cord MSCs dynamically increasing from only 1 million cells initially in a seed microcarrier to 15.2 million after 7 days of culture. on site It shows that it can grow and expand by the method of serial generation.
[0331] Example 6: 3D microcarrier-based on site Cell cryopreservation method
[0332] I.
[0333] The cells in the section were HEK293T cells purchased from the Cell Resource Center of Beijing Union Medical University under catalog number CBP60439. The 3D microcarrier was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. under catalog number CNF-F01T-50.
[0334] In the example, the three-dimensional microcarrier suspension of cells was prepared according to the following steps.
[0335] 1. Preparation of microcarriers: 200 mg of microcarrier powder was measured for UV sterilization and poured into a sterile cell culture flask equipped with an impeller (see Fig. 1). Three groups were prepared.
[0336] 2. Cell preparation: Prepare an adipose-derived MSC suspension in advance and 5 x 10 6 Resuspend the cells in 60 mL of complete medium for later use. Three groups were prepared.
[0337] 3. Cell Inoculation: The above cell suspension was mixed in a cell culture flask equipped with an impeller and thoroughly mixed with 200 mg of microcarrier;
[0338] 4. Cell Attachment: Place a cell culture flask equipped with an impeller on a low-speed stirrer, place it in a 37°C, 5% CO2 incubator, and stir at 80 rpm to allow the cells to rotate and attach to the microcarrier;
[0339] 1. A three-dimensional microcarrier suspension containing HEK293T cells was centrifuged at 400xg for 2 minutes, and the supernatant was discarded.
[0340] 2. A cryopreservation solution (90% FBS + 10% DMSO) was added and distributed into cryopreservation tubes (1 ml of cryopreservation solution contains 10 mg of cell-containing microcarriers, 0.5 to 1 ml per tube).
[0341] 3. Place the cryogenic storage tube into a cell-programmed cooling box, place it in a -80°C refrigerator within 5 minutes, and transfer it to liquid nitrogen after 24 hours.
[0342] 4. Recovery of cells attached to microcarriers: For recovery, basal medium preheated to 37°C was prepared, and the cryogenic storage tube was rapidly placed in a 37°C water bath and gently shaken continuously during this time. When a grain of rice-sized ice remained (approximately 1–2 minutes in the bath), the tube was quickly removed from the bath. Subsequently, the molten 3D microcarrier suspension containing the cells was immediately diluted with basal medium at a 1:5 ratio, centrifuged at 400xg for 2 minutes, and resuspended for future use.
[0343] 5. Cell detection method:
[0344] (1) living cells On site Calcein-AM / PI Staining Method:
[0345] 1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0346] 2) 50 to 100 µl of a three-dimensional microcarrier suspension containing cells recovered before or after cryopreservation was added to each 96-well plate;
[0347] 3) The supernatant was removed as much as possible, and the wells were washed once with PBS. After 2 minutes, the PBS was removed as much as possible, and 100 μL of the staining solution prepared according to the kit instructions was added to each well for staining. The wells were stained at room temperature for 20–30 minutes, and after blocking light, observed under a fluorescence microscope. The results are shown in Figure 26.
[0348] As shown in Fig. 26, living cells were stained with a staining solution and observed to emit light due to fluorescence; the glowing cells were living cells. The illuminated spherical microcarriers demonstrated that the living cells remained attached to the microcarriers. Fig. 26A shows that the living cells on site It shows that it can be cryopreserved and recovered from 3D FloTrix microcarriers. It is even successful after 2 weeks of cryopreservation. However, in Fig. 26B, after cryopreserving and recovering a competitor's microcarrier (GE Cytodex, catalog number: 17-1271-01, purchased from Beijing Think-Far Technology Co., Ltd.), it was found that the cells detached from the microcarrier and, by fluorescence observation, the cells did not adhere to the microcarrier and scattered as dots in the liquid.
[0349] (2) Analytical method for detecting apoptosis rate by flow cytometry:
[0350] 1) Cell Collection: A 20 mg three-dimensional microcarrier suspension containing cells was centrifuged at 400 xg for 2 minutes, and the supernatant was discarded. 3 mL of 0.1% Collagenase Type IV solution (1 g of Collagenase Type IV (Gibco, 17104019) dissolved in 1 L of PBS) was added, and the solution was incubated in a cell incubator at 37°C for 30 minutes, followed by centrifugation at 400 xg for 5 minutes, after which the supernatant was discarded.
[0351] 2) Cell washing: Cells were resuspended once in PBS pre-cooled at 4°C, centrifuged at 400 xg for 5 minutes, and then washed.
[0352] 3) Cell Staining: Cells were stained using the Annexin V-FITC / PI Apoptosis Detection Kit (HaiGene Biotech Co., Ltd, S0185). Specifically, 300 μL of Binding Buffer was added, followed by 5 μL of Annexin V-FITC, mixed, and incubated for 15 minutes at room temperature protected from light; then, 5 μL of PI was added for staining for 5 minutes. 200 μL of Binding Buffer was added.
[0353] 4) Cell Flow Cytometry: Flow cytometry of stained cells was performed using a BD FACSAria II flow cytometer, and a cell classification analysis report was generated by the instrument.
[0354] 5) Interpretation of the cell flow cytometry report:
[0355] A) Annexin-V negative - PI negative represents normal cells, i.e., the ratio of cells to living cells, in the bottom-left group of the 4-frame cell classification diagram.
[0356] B) Annexin-V positive - PI negative represents cells in the early stages of apoptosis, i.e., the bottom right group of the 4-frame cell classification diagram, and the cell ratio is the proportion of cells in the early stages of apoptosis.
[0357] C) Annexin-V positive - PI positive represents cells in the late stage of apoptosis or necrotic cells, i.e., the top right group in the 4-frame cell classification diagram, and the cell ratio is the proportion of cells in the late stage of apoptosis.
[0358] Figure 27 shows that the percentage of viable cells in the 3D FloTrix microcarrier before cryopreservation is 90.4%. On the other hand, the percentage of viable cells recovered after cryopreservation was 89.6%, and due to a decrease of less than 1%, the cells of the 3D FloTrix microcarrier used in the present invention together with the microcarrier on siteIt can be preserved and maintain activity even after recovery.
[0359] (3) In-situ Cell counting method:
[0360] 1) Microcarrier collection: 20 mg of a 3D microcarrier suspension containing cells was collected through a 70 μm cell sieve, and cells not attached to the microcarrier were washed once with PBS. Subsequently, the microcarrier suspension containing cells was centrifuged at 1500 rpm for 2 minutes, and the supernatant was discarded.
[0361] 2) Cell counting: Cells were counted using 3 mL of 0.1% crystal violet solution (0.1 g crystal violet, 2.1 g citric acid, 20 μL Tween-80, 100 ml deionized water) and a cell counting plate at 37°C for 2 to 5 hours.
[0362] 3) Analysis of results: The results of Figure 28 show that the number of cells in the 3D FloTrix microcarrier after cryopreservation and recovery remained consistent with that before cryopreservation, whereas the number of cells in the competing microcarrier (GE Cytodex, catalog number: 17-1271-01, purchased from Beijing Think-Far Technology Co., Ltd.) decreased significantly due to rupture of the microcarrier and scattering of cells. Therefore, the present invention allows for in situ 3D cell freezing by using the 3D FloTrix microcarrier for cell culture, followed by cryopreservation and recovery, thereby maintaining the entire chain of the cell culture and preservation process in a 3D environment.
[0363] II.
[0364] The cells in the section were AD-MSC cells (Tsinghua University School of Medicine); the 3D microcarrier was a 3D FloTrix microcarrier purchased from Beijing CytoNiche Biotech Ltd. with catalog number CNF-F01T-50.
[0365] 1. The 3D microcarrier suspension containing AD-MSC cells was centrifuged at 400xg for 2 minutes, and the supernatant was discarded.
[0366] 2. A cryopreservation solution (90% FBS + 10% DMSO) was added and distributed into cryopreservation tubes (1 ml of cryopreservation solution contains 10 mg of cell-containing microcarriers, 0.5 to 1 ml per tube).
[0367] 3. Place the cryogenic storage tube into a cell-programmed cooling box, place it in a -80°C refrigerator within 5 minutes, and transfer it to liquid nitrogen after 24 hours.
[0368] 4. Recovery of cells attached to microcarriers: For recovery, basal medium preheated to 37°C was prepared, and the cryogenic storage tube was rapidly placed in a 37°C water bath and gently shaken continuously during this time. When a grain of rice-sized ice remained (approximately 1–2 minutes in the bath), the tube was quickly removed from the bath. Subsequently, the molten 3D microcarrier suspension containing the cells was immediately diluted with basal medium at a 1:5 ratio, centrifuged at 400 xg for 2 minutes, and resuspended for future use.
[0369] 5. Cell detection method:
[0370] (1) living cells On site Calcein-AM / PI Staining Method:
[0371] 1) Kit: Live & Dead Viability / Cytotoxicity Assay Kit for Animal Cells, Catalog No.: KGAF001;
[0372] 2) 50 to 100 µl of a three-dimensional microcarrier suspension containing cells recovered before or after cryopreservation was added to each 96-well plate;
[0373] 3) The supernatant was removed as much as possible, and the wells were washed once with PBS. After 2 minutes, the PBS was removed as much as possible, and 100 μL of the staining solution prepared according to the kit instructions was added to each well for staining. The wells were stained at room temperature for 20–30 minutes, and then observed under a fluorescence microscope after blocking light. The results are shown in Figure 29.
[0374] As shown in Fig. 29, living cells were stained with a staining solution and observed to emit fluorescence, and the glowing cells were living cells. The illuminated spherical microcarriers demonstrated that the living cells remained attached to the microcarriers. Fig. 29 shows the results of recovering AD-MSCs after 1–2 days of cryopreservation on 3D FloTrix microcarriers. The glowing living cells remained attached to the microcarriers, indicating that 3D FloTrix supports the cryopreservation of MSCs.
[0375] FIG. 30 shows that the MSCs on the 3D FloTrix microcarrier had a viable cell ratio of over 90% before and after cryopreservation, and there was no significant difference in cell activity before and after cryopreservation. Therefore, the MSCs on the 3D FloTrix microcarrier used in the present invention, together with the microcarrier on site They can be preserved and maintain their activity even after recovery.
[0376] (3) Lysed cell counting method:
[0377] 1) Microcarrier collection: 20 mg of a 3D microcarrier suspension containing cells was collected through a 70 μm cell sieve, and cells not attached to the microcarrier were washed once with PBS. Subsequently, the microcarrier suspension containing cells was centrifuged at 1500 rpm for 2 minutes, and the supernatant was discarded.
[0378] 2) Cell Count: 3 mL of lysis solution (lysis solution formulation: 0.1% collagenase, 0.1% ethylenediaminetetraacetic acid, 0.05% trypsin; % indicated g / 100 mL) was added, and the mixture was incubated in an incubator for 30 minutes. During this time, cells were gently blown in several times using a 1 mL pipette every 10 minutes; after 30 minutes, the microcarrier was completely dissolved, and 3 mL of total medium was added to terminate the lysis process; the tube was centrifuged at 200 x g for 5 minutes, the supernatant was discarded, the cells were resuspended, and counted using a cell counting plate.
[0379] 3) Analysis of results: The results of Figure 31 show that the number of cells in the 3D FloTrix microcarrier after cryopreservation and recovery remained consistent with that before cryopreservation. Therefore, the use of the 3D FloTrix microcarrier for MSC culture in the present invention allows for long-term cryopreservation, maintenance of the entire chain of cell culture, and preservation in a three-dimensional environment.
[0380] Example 7: Large-scale proliferation of stem cells using a 3D culture method
[0381] I. Continuous cell expansion culture in a stirred bioreactor
[0382] 1. Ten 3D TableTrix microcarriers (Beijing CytoNiche Biotech Ltd., Catalog No.: F01-100) (total 200 mg) were added to a cell culture flask with an impeller (Bellco Glass, USA, Catalog No.: 1965-61001) and 10 ml of cell culture medium.
[0383] 2. 50 mL of adipose-derived MSC cell suspension (containing 2 million cells) was inoculated into a cell culture flask equipped with an impeller containing the microcarrier prepared in step 1.
[0384] 3. A cell culture flask with a built-in 2-stage impeller in a cell culture incubator 3D FloTrix miniSpin small-scale bioreactor (Beijing CytoNiche The cells were placed in a Biotech Ltd. 3D miniSPIN M1 and incubated at a constant speed of 60 rpm clockwise for 6 days (replenished with 60 mL of fresh medium on the 3rd day). Cell sampling and counting were performed daily to obtain data on the cell expansion curve. On the 6th day, a microstructure containing 20 million cells (i.e., a microcarrier containing cells) from a cell culture flask with an impeller was resuspended in 50 mL of fresh medium using an electric pipette and transferred to a 3D FloTrix vivaSpin bioreactor (Beijing CytoNiche Biotech Ltd., 3D vivaSPIN V1, Fig. 33) and 50 previously resuspended 3D TableTrix microcarriers (Beijing CytoNiche Biotech Ltd., Catalog No.: F01-100) (total 1 g) left for 0–30 minutes) in 50 mL of medium, and cells were sampled and counted daily to obtain data on the cell expansion curve and measure cell activity.
[0385] The process parameters established for the 3D FloTrix vivaSpin bioreactor were controlled throughout the process with 5% CO2 active pumping of 12 cc / m and a temperature of 37°C. 800 mL of complete medium was actively pumped at a rate of 10 mL / min at T = 0 hours, 500 mL of liquid was actively pumped at a rate of 10 mL / min, followed by 500 mL of fresh medium at 1 hour. At T = 96 hours, 500 mL of liquid was actively pumped at a rate of 10 mL / min, followed by purification of 50 3D TableTrix microcarriers resuspended in 500 mL of fresh medium at 10 mL / min at T = 144 hours. The stirring speed for T = 0 to 12 hours and T = 144 to 156 hours was a variable speed with a constant speed cycle of 40 rpm for 5 minutes, 20 rpm for 20 minutes, and 60 rpm for the remainder of the time.
[0386] Cell Sampling and Counting Method: All samples were collected by pipetting 1 mL of sample x 3 replicas through the sampler of the 3D FloTrix vivaSpin bioreactor, transferred to a centrifuge tube, centrifuged at 400xg for 2 minutes, and pipette the supernatant. 1 mL of lysis solution (lysis solution formulation: 0.1% collagenase, 0.1% ethylenediaminetetraacetic acid, 0.05% trypsin; % indicated g / 100 mL) was added, and the mixture was incubated in an incubator for 30 minutes until the microcarrier was completely dissolved. During this time, the cells were gently blown in several times every 10 minutes using a 1 mL pipette, and 1 mL of total medium was added to terminate the lysis process. The mixture was centrifuged at 200xg for 5 minutes, the supernatant was discarded, the cells were suspended, and counted using a cell counting plate.
[0387] Cell activity analysis: 50 μL of cell suspension was mixed with 50 μL of 0.2% Trypan Blue staining solution, and an appropriate amount of cells were taken and counted. An automated cell counter (e.g., Countstar® BioTech, Shanghai Ruiyu Biotech Co., Ltd.) or a cell counter plate may be used. The number of crystal-clear cells and the number of blue-stained cells were recorded separately, and the number of cells in the cell suspension was extrapolated at the corresponding dilution ratio.
[0388] Cell activity rate (%) = Number of unstained cells / (Number of unstained cells + Number of blue-stained cells) × 100%.
[0389] The results of the cell count analysis are shown in Fig. 32. The entire culture process was maintained for a total of 14 days, from the time 2 million cells were directly inoculated into 10 Microcarriers in a cell culture flask of a 3D FloTrix® miniSpin with an impeller until new Microcarriers were added. The process was expanded to a 3D FloTrix® viviSpin automated bioreactor to reach a final harvest of 100 million cells for an additional 8 days of culture. Of these, 49.2 million cells were harvested from the initial 2 million in the small-scale bioreactor after 6 days of culture from day 0 to day 6, indicating an approximate 24.6-fold increase in proliferation; and a total of approximately 259 million cells were harvested from the seed after 8 days of culture in the automated bioreactor, indicating an approximately 52.7-fold increase in proliferation. In other words, the total expansion over 14 days of culture was approximately 1,295-fold.
[0390] The results of the cell activity analysis are shown in Figure 34. As a result, it was found that cell activity was maintained at over 90% throughout the entire culture process. The entire culture process was carried out by only one person requiring less than 0.25 m² of space, 14 days of culture time, 2 liters of culture medium, and 110 micro-carriers, thereby significantly saving human, material, and financial resources.
[0391] II. Continuous cell expansion in a 3D FloTrix vivaSpin bioreactor (1000 mL)
[0392] 1. Forty tablets of 3D TableTrix microcarriers were added to a sterile 3D FloTrix vivaSpin bioreactor with 40 mL of 6.6 million lipid-derived MSC suspension on a sterile workbench.
[0393] 2. A bioreactor was assembled and process parameters were set to control as follows: 5% CO2 active pumping of 10 cc / m throughout the process and a temperature of 37°C. 460 mL of complete medium was actively pumped at a rate of 10 mL / min at T = 0 hours, followed by 500 mL of liquid being actively pumped at a rate of 10 mL / min at T = 48 hours. Thereafter, every 24 hours, 500 mL of liquid was actively pumped at a rate of 10 mL / min, followed by 500 mL of fresh medium being actively pumped into the reactor at a rate of 10 mL / min up to 120 hours. At T = 120 hours, 500 mL of liquid n was actively pumped at 10 mL / min, after which 40 tablets of 3D TableTrix microcarriers resuspended in 500 mL of fresh medium were actively pumped into the reactor at a rate of 10 mL / min. The stirring speed was a constant 60 rpm during T = 0 to 120 hours; during T = 120 to 136 hours, the stirring speed was variable in cycles of 60 rpm for 5 minutes and 20 rpm for 20 minutes; during T = 136 to 240 hours, the stirring speed was a constant 60 rpm (after 240 hours, the stirring mode was a constant 60 rpm). Cells were sampled and counted daily to obtain data on the cell expansion curve and to measure cell activity.
[0394] The results are shown in Figures 35 and 36. The results show that adipose-derived MSCs expanded from 6.6 million cells inoculated onto 40 purified microcarriers in a 3D FloTrix vivaSpin bioreactor to 2.24 x 10⁹ cells. Microcarriers (resuspended in medium) that achieved approximately 340-fold expansion after being pumped on day 6 and cultured under complete blockade for 10 days. The activity of adipose-derived MSCs in the 3D FloTrix vivaSpin bioreactor was consistently maintained at over 90%.
[0395] III. Partial Characterization of MSCs Cultured in Two-Dimensional Flasks and Three-Dimensional Microcarriers Using Flow Cytometry
[0396] The microtissues cultured in steps 1 and 2 were centrifuged from the cell suspension at 200 µg for 5 minutes according to the patent application "A method for Harvesting Cells on Three-dimensional Microcarrier" (Chinese Patent Application No. 201910101736.0), the supernatant was discarded, the microtissues were washed with PBS, and PE-CD19 (Biolegend, USA, Catalog No.: 302207), APC-CD14 (Biolegend, USA, Catalog No.: 301803), FITC-CD34 (Biolegend, USA, Catalog No.: 343503), APC-CD45 (Biolegend, USA, Catalog No.: 368511), FITC-HLADR (Biolegend, USA, Catalog No.: 307603), FITC-CD90 (Biolegend, USA, Catalog No.: 328107), FITC-CD105 (Biolegend, USA, Catalog No.: 800505) and FITC-CD73 (Biolegend, USA, Catalog No.: 344015) were fluorescently labeled antibodies and an empty buffer was used as a negative control, respectively. After incubation in a refrigerator at 4°C for 0.5 hours, cells were washed twice in PBS, resuspended in PBS, and transferred to a flow tube. Stained cells were flow-cytosed using a BD FACSAria II flow cytometer, and the expression rates of MSC-specific surface markers were reported by the instrument for cell classification analysis.
[0397]
[0398] The data showed that MSCs cultured on a large scale in 3D microcarriers had expression profiles similar to those cultured in conventional 2D, and both met qualification criteria.
[0399] The above data suggested that the use of three-dimensional microcarriers for large-scale MSC culture is feasible, cost-effective, and can be carried out in a closed system with high process control and minimal space occupation.
[0400] applied industry
[0401] The present invention relates to a three-dimensional microcarrier-based cell recovery method and a three-dimensional microcarrier-based cell culture method. on site Provides a set of 3D microcarrier-based cell culture methods, including subculturing and 3D microcarrier-based cell culture. A method for large-scale cell proliferation, 3D microcarrier-based on site Cell cryopreservation method, cell attachment culture method on a 3D microcarrier, cell harvesting method on a 3D microcarrier and cell sampling method culture on a microcarrier.
[0402] The 3D microcarrier-based cell recovery method provided by the present invention can be completed by using a 3D microcarrier as a substrate to directly recover cells or microtissues and then inoculating them onto a new carrier (microcarrier recovery method). Through the processes of cell attachment, adhesion, and growth on the microcarrier, the complex task of recovering cells to a 2D substrate, allowing them to grow fully first, and then harvesting them before inoculating them onto a new culture substrate can be avoided. Because the microcarrier has high elasticity, it mitigates irritation caused by collisions between newly revived cells and the microcarrier, which are prone to breakage during dynamic incubation; furthermore, softer and porous microcarriers have a larger specific surface area, providing more space for wall attachment. The porous structure also allows fragile cells to burrow into pores that are less sensitive to the shear forces of the flowing medium. Since this method allows for cell passage without interrupting the 3D culture process, it is intended to maintain cells in a 3D state throughout the preparation of 3D culture cell products or tissue engineering products, thereby providing some innovation, complement, or experience in the fields of completely enclosed cell culture, continuous expansion, and cell recovery. Advantages of the 3D microcarrier-based cell recovery method: (1) When recultured in 3D, the process is simplified to eliminate the cumbersome processes and reagent consumables required for single-cell processing. After the cells grow to full size, they are collected and cryopreserved to be recovered as a 2D culture substrate, and then subcultured and digested before inoculating them onto a microcarrier for 3D culture, thereby saving a significant amount of time and cost. (2) The obtained cells are similar to in vivo cells, and since the recovery for cell culture, subsequent cryopreservation, and reculture is maintained in a manner similar to the in vivo 3D environment, the obtained cells are similar to in vivo cells in terms of physiology and function.
[0403] The subculture method based on 3D microcarrier cell culture provided in the present invention achieves "elemental subculture" by inoculating a cultured microcarrier (i.e., a seed microcarrier) into a new microcarrier. Cells attach, spread, expand, proliferate, and migrate to the 3D microcarrier, then flow from the seed microcarrier to attach to the new microcarrier, and subsequently proliferate and grow on the new microcarrier. The seed microcarrier makes contact, and the cells on the seed microcarrier migrate, transferring the cells on the seed microcarrier to the new microcarrier where they continue to proliferate and grow; by cleverly utilizing this process, "in situ subculture" of cells in the 3D microcarrier is achieved. Based on 3D microcarrier cell culture on site Advantages of the passage method: (1) By avoiding traditional two-dimensional cell digestion and passage, it not only reduces cell damage caused by digestion solutions but also saves significant manpower and resources in large-scale culture expansion by eliminating the tedious digestion and passage process, and obtains high-quality cells. (2) It saves time; while digesting and inoculating cells takes time, the passage method saves time. (3) The choice of on-site passage eliminates the need for consumables such as reagents and digestion solutions, simplifies the process, and reduces costs.
[0404] 3D microcarrier-based provided in the present invention on site The cell cryopreservation method allows for the in situ cryopreservation of cell cultures on three-dimensional microcarriers without the need to separate cells from the microcarriers and then cryopreserve them, but on three-dimensional microcarriers on siteIt is preserved directly. Because this method ensures that the microcarrier does not break or deform during cryopreservation (from -20 to -196°C up to liquid nitrogen storage) and retrieval (i.e., heating and thawing from liquid nitrogen or -80°C), cells can be cryopreserved without interrupting the 3D culture process. Furthermore, since the cells remain attached to the 3D microcarrier, they are maintained in a 3D state throughout the manufacturing of 3D cultured cell products or tissue engineering products, facilitating storage, transportation, and retrieval. This method is suitable for the long-term preservation of cells cultured on 3D microcarriers, which have high viability and maintain cell characteristics after retrieval.
[0405] The cell attachment culture method for a three-dimensional microcarrier provided in the present invention utilizes a high-density, low-volume method in which the three-dimensional microcarrier is directly swollen using a cell suspension. The cell suspension is absorbed by the microcarrier immediately after being added to the dried three-dimensional microcarrier, thereby promoting the direct attraction of cells into the pores of the microcarrier upon inoculation. This disperses the cells within the pores of the microcarrier and provides the cells with a larger growth area for attachment regrowth. On the other hand, it simplifies the process of inoculating cells into the microcarrier by saving the step of pre-swelling the microcarrier. Aseptic operation of the culture is easier, and the risk of contamination is prevented. This method is suitable for large-scale bioreactor culture. The unique swelling absorption characteristics of the three-dimensional microcarrier allow a large number of cells to enter the connected pores of the carrier, thereby better forming bioengineered three-dimensional growth patterns and promoting function during in vitro cell culture.
[0406] The method for harvesting cells on a three-dimensional microcarrier provided by the present invention relates to harvesting cells on a three-dimensional microcarrier. As cells are cultured on a three-dimensional microcarrier, the present invention enables gentle harvesting of cells on the carrier for subsequent application; the present invention targets a lysis microcarrier, which dissolves the microcarrier from a solid to a liquid state to release cells on the carrier into a solution, which is then separated from the cells by centrifugation to obtain the cells. The lysis solution of the present invention is designed for microcarriers and can be tailored to the composition of the microcarrier; and since the lysis solution dissolves the microcarrier, it acts gently on the cells, maintains cell activity, and preserves proteins secreted by the cells themselves.
[0407] When comparing the method of sampling cells cultured on a microcarrier provided in the present invention with the conventional suspension quantitative sampling method, the three cell samples counted in the microcarrier culture system using the quantitative microcarrier sampling method provided in the present invention are reproducible (with small deviation) and very close to the actual sum.
[0408] The large-scale expansion method for cells based on three-dimensional microcarriers provided by the present invention demonstrates that large-scale culture of MSCs using three-dimensional microcarriers is feasible, cost-effective, and can be performed in a higher level of closed system with process control and minimal space occupation. This reduces the cost and time of cell production, enabling the large-scale preparation of cell therapy products for clinical use.
[0409] The present invention is very important for the three-dimensional culture of cells, especially stem cells.
Claims
Claim 1 i) 3D microcarrier-based cell recovery method, ii) 3D microcarrier cell culture-based in situ iii) 3D microcarrier-based in situ A set of cell culture methods based on a three-dimensional microcarrier, comprising a cell cryopreservation method, wherein i) a cell recovery method based on a three-dimensional microcarrier comprises the step of inoculating a cell suspension of a cell or a cryopreserved cell microtissue, after thawing, onto a three-dimensional microcarrier for cell recovery and culture, and ii) a three-dimensional microcarrier cell culture-based in situ The subculturing method includes a step of inserting a seed microcarrier into a new microcarrier, wherein the seed microcarrier is a microcarrier cultured together with the cells to be subcultured, and iii) 3D microcarrier-based in situ A cell cryopreservation method comprises: (A1) centrifuging a three-dimensional microcarrier suspension of cells and discarding the supernatant to obtain a cell-containing carrier; (A2) mixing the cell-containing carrier obtained in step (A1) with a cryopreservation solution and adding it to a cryogenic storage tube; and (A3) the cells from the three-dimensional microcarrier in step (A2) in situ The set of cell culture methods based on a three-dimensional microcarrier further comprises the step of cooling a cryogenic storage tube containing a cell carrier capable of cryopreservation and then transferring it to liquid nitrogen, wherein the set of cell culture methods based on a three-dimensional microcarrier further comprises iv) a cell attachment culture method for a three-dimensional microcarrier to inoculate cells onto the three-dimensional microcarrier, and the cell attachment culture method for a three-dimensional microcarrier comprises (B1) cell inoculation: a step of directly mixing a cell suspension with a dried three-dimensional microcarrier to obtain a microcarrier mixed with the cell suspension; (B2) cell attachment: a step of culturing the microcarrier mixed with the cell suspension obtained in step (B1) to allow cells to attach to the three-dimensional microcarrier; and (B3) cell culture: a step of adding a complete culture medium and culturing after cell attachment in step (B2), and the set of cell culture methods based on a three-dimensional microcarrier further comprises v) a method for harvesting cells on the three-dimensional microcarrier and vi) a method for sampling cells cultured on the microcarrier; A method for harvesting cells on a three-dimensional microcarrier is used to isolate cells from a three-dimensional microcarrier; a method for sampling cells cultured on a microcarrier is used to perform calculations of the total number of cells and cell density of cells cultured on a microcarrier, and v) a method for harvesting cells on a three-dimensional microcarrier comprises: (C1) a step of naturally settling or centrifuging a three-dimensional microcarrier to which cultured cells are attached, and removing the supernatant to obtain a three-dimensional microcarrier containing cells; (C2) a step of adding a lysis solution to the three-dimensional microcarrier containing cells and culturing and lysing the three-dimensional microcarrier inside; (C3) a step of completely lysing the three-dimensional microcarrier in step (C2), adding a termination solution to terminate the lysis, or proceeding directly to step (C4) to terminate the lysis; (C4) a step of centrifuging the system obtained in step (C3), discarding the supernatant, and harvesting cells on the three-dimensional microcarrier;vi) A method for sampling cells cultured on a microcarrier comprises: (D1) weighing a certain weight of microcarrier for cell culture, placing it in a sampling tube, adding a liquid to simulate the cell culture process, and immersing it at 4 to 60°C for 0 to 24 hours, after which marking a scale corresponding to the volume occupied by the microcarrier on the sampling tube as a reference scale; (D2) sampling cells cultured on the microcarrier by the following steps: sampling the microcarrier from the cell culture system with a sampling tube so that the volume of the microcarrier reaches the reference scale; characterized in that the set of three-dimensional microcarrier-based cell culture methods is provided. Claim 2 delete Claim 3 In claim 1, the three-dimensional microcarrier-based cell recovery method is a three-dimensional microcarrier-based dynamic cell recovery method or a three-dimensional microcarrier-based static cell recovery method; the three-dimensional microcarrier-based dynamic cell recovery method comprises: (E1) taking a three-dimensional microcarrier, placing it in a cell culture vessel, adding cell culture medium, and immediately proceeding to the next step, or allowing it to stand or stirring for at least 1 minute; (E2) inoculating a cell suspension of cryopreserved cells or cryopreserved cell microtissues thawed at 37°C into a cell culture vessel containing the microcarrier prepared in (E1), adding cell culture medium, and adjusting the ratio of microcarrier to medium to 1 mg : 1 to 1000 μL; and placing the cell culture vessel on a stirrer and stirring in an incubator. (E3) A step of continuing to stir the cells until cell recovery is completed after (E2) is completed; and a three-dimensional microcarrier-based static cell recovery method comprising (F1) a step of preparing a static culture vessel and a microcarrier, wherein a three-dimensional microcarrier is taken and placed in a cell culture vessel; (F2) a step of thawing and inoculating cryopreserved cells, wherein a cryopreserved cell or cryopreserved cell microtissue is taken, thawed at 37°C, and then inoculated into a static culture vessel containing the microcarrier prepared in (F1) for 20 to 240 minutes; (F3) a step of continuing cell culture until cell recovery is completed after (F2) is completed; a set of three-dimensional microcarrier-based cell culture methods. Claim 4 A set of three-dimensional microcarrier-based cell culture methods according to claim 3, wherein the stirring in step (E2) is constant speed stirring, variable speed alternating stirring, or variable speed cyclic stirring; the stirring direction is clockwise, counterclockwise, or alternating; the stirring time is 0.1 to 100 hours; the stirring speed is 1 to 200 rpm; and the stirring is characterized by (a) stirring in a clockwise direction at a variable speed cyclically for 1 to 24 hours after leaving for 1 to 4 hours, followed by stirring in a clockwise direction at a constant speed up to 96 hours; (b) stirring in a clockwise direction at a variable speed cyclically for 1 to 24 hours, followed by stirring in a clockwise direction at a constant speed up to 96 hours; or (c) stirring in a clockwise direction at a constant speed for 1 to 96 hours. Claim 5 In claim 1, the three-dimensional microcarrier cell culture base in situ The subculture method is a dynamic method based on 3D microcarrier cell culture. in situ Static based on subculture or 3D microcarrier cell culture in situ It is a passage method; dynamic based on 3D microcarrier cell culture in situ The subculturing method comprises: (G1) a step of preparing a new microcarrier suspension, wherein the new microcarrier is placed in a cell culture flask equipped with an impeller, cell culture medium is added at a ratio of 1 to 2,000 μL per 1 mg of microcarrier, and the mixture is left to stand or stirred for at least 0 hours to obtain a new microcarrier suspension; (G2) a step of preparing a seed microcarrier suspension, wherein the seed microcarrier has a cell density of 10,000 to 1 million cells / mg of microcarrier, and the seed microcarrier is resuspended in cell culture medium at a concentration of 0.1 to 50 mg / mL to obtain a seed microcarrier suspension; (G3) As an inoculation step, the seed microcarrier suspension prepared in (G2) is mixed into a cell culture flask equipped with an impeller containing the new microcarrier suspension prepared in (G1), wherein the ratio of seed microcarrier to new microcarrier is 0.0002 to 200 mg seed microcarrier / mg new microcarrier, and then cell culture medium is added to adjust the ratio of microcarrier to medium to 1 mg:1 to 1000 μL, and the cell culture flask equipped with an impeller is placed on a stirrer and placed in an incubator to be stirred for 0 to 100 hours; (G4) As a culture step, dynamic in situ A step of continuously stirring to complete passage; including, and a static 3D microcarrier cell culture-based method in situ The subculturing method comprises: (H1) a step of preparing a seed microcarrier suspension, wherein the seed microcarrier has a cell density of 10,000 to 1,000,000 cells / mg microcarrier and the seed microcarrier is resuspended in cell culture medium to a concentration of 0.1 to 50 mg / mL to obtain a seed microcarrier suspension; (H2) an inoculation step, wherein the seed microcarrier suspension prepared in (H1) is dropwise added to a new microcarrier, the ratio of seed microcarrier to new microcarrier is 0.0002 to 200 mg seed microcarrier / mg new microcarrier, and the seed microcarrier and new microcarrier are mixed and then placed in an incubator to be cultured for 0.5 to 24 hours; (H3) a culture step, wherein cell culture medium is added and culture is continued to a constant in situ A set of three-dimensional microcarrier-based cell culture methods characterized by including a step of completing passage. Claim 6 In claim 5, at step (G1), the ratio of new microcarrier to cell culture medium in a cell culture flask with an impeller is 100 mg microcarrier / 10 mL cell culture medium; and after placing the new microcarrier and cell culture medium into the cell culture flask with an impeller, the mixture is left to stand for 0.1 to 24 hours; at step (G2), the cell density of the seed microcarrier may be 150,000 to 500,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension is 1 to 10 mg / mL; at step (G3), the ratio of the seed microcarrier to the new microcarrier is 1 to 10 mg seed microcarrier / 100 mg new microcarrier; and the ratio of the microcarrier to the medium is adjusted to 1 to 10 mg:1 mL by adding cell culture medium; A set of three-dimensional microcarrier-based cell culture methods characterized by: a stirring speed of 1 rpm to 200 rpm, stirring being constant speed stirring, variable speed alternating stirring, or variable speed cyclic stirring, and stirring direction being clockwise stirring, counterclockwise stirring, or alternating stirring; in step (H1), the cell density of the microcarrier is 120,000 to 500,000 cells / mg microcarrier; and the content of the seed microcarrier in the seed microcarrier suspension is 5 to 15 mg / mL; in step (H2), the ratio of the seed microcarrier to the new microcarrier is 1 to 3 mg seed microcarrier / 20 mg new microcarrier; and an incubation time of 0 to 24 hours. Claim 7 In claim 1, the three-dimensional microcarrier-based in situ In a cell cryopreservation method, in step (A1), centrifugation is performed at a speed of 50 to 1610 khg for a time of 1 to 10 minutes; in step (A2), the mass ratio of the volume of the cryopreservation solution to the cell-containing carrier is 1 mL:0.1 to 50 mg; and the three-dimensional microcarrier-based in situ In a cell cryopreservation method, the cryopreservation solution comprises 10 vol% DMSO, 10 to 90 vol% FBS, and 0 to 80 vol% basic medium; the cryopreservation tube is placed in a refrigerator and cooled to -20 to -196°C, wherein the cooling is programmed or not programmed, and the programmed cooling has a cooling rate of -1 to -15°C / min and a cooling time of 1 to 24 hours; and the three-dimensional microcarrier-based in situ A set of three-dimensional microcarrier-based cell culture methods characterized in that, in a cell cryopreservation method, the cryopreservation tube of step (A2) is placed in a cell cooling box and cooled in a refrigerator within 1 to 10 minutes, and the PBS or basic medium preheated to 37°C added to the cryopreservation tube is diluted at a ratio of 1:5 to 30. Claim 8 In claim 1, the three-dimensional microcarrier-based in situ A set of three-dimensional microcarrier-based cell culture methods, wherein a cell cryopreservation method further comprises a cell recovery step after step (A3), wherein the cell recovery step comprises placing a cryopreservation tube in a water bath after the treatment of step (A3), and removing the water bath to recover the storage tube when the ice in the cryopreservation tube melts; then adding PBS or a basic medium preheated to 37°C to dilute the cells and then centrifuging; wherein the temperature of the water bath is 35 to 40°C and the water bath treatment time is 1 to 5 minutes, and the centrifugation performed after step (A3) is performed at a speed of 50 to 1610 Kg for 1 to 10 minutes. Claim 9 In claim 1, in the cell adhesion culture method on the three-dimensional microcarrier, the density of the cell suspension is 1×10 4 Up to 1X10 8 cells / mL; the cell suspension is obtained by resuspending cells in a culture medium or a liquid biological substrate; the ratio of the volume of the cell suspension to the mass of the three-dimensional microcarrier is 1 to 1000 μL: 1 mg; in step (B1), the cell suspension is mixed with the three-dimensional microcarrier by adding dropwise to the three-dimensional microcarrier; in the cell attachment culture method on the three-dimensional microcarrier, the incubation conditions are a temperature of 35 to 40°C, 0.5 to 24 hours, and a carbon dioxide concentration percentage of 5 to 30% by volume; the attachment method includes a gravity attachment method, a swelling attachment method, a stirrer rotation attachment method, a centrifugation method, a surface acoustic wave method, or a magnetic attachment method; in the cell attachment culture method on the three-dimensional microcarrier, the culture conditions are a temperature of 35 to 40°C and a carbon dioxide concentration percentage of 5 to 30% by volume; the three-dimensional microcarrier is a porous microcarrier; A set of cell culture methods based on a three-dimensional microcarrier, characterized in that a step of gas sterilizing, radiation sterilizing, or UV sterilizing the three-dimensional microcarrier precedes step (B1). Claim 10 In claim 1, in a method for harvesting cells on a three-dimensional microcarrier, the lysate comprises an active ingredient for dissolving the microcarrier while dissociating cell attachments, wherein the active ingredient is selected from one or more aqueous solutions of collagenase, pepsin, hyaluronidase, dispase, neutral protease, proteinase K, matrix metalloproteinase, sodium citrate, trypsin, deoxyribonuclease, trypsin substitute, protein hydrolase, ethylene diamine tetraacetic acid, lysozyme, and glutathione; and in a method for harvesting cells on a three-dimensional microcarrier, the A set of cell culture methods based on a three-dimensional microcarrier, characterized in that, in step (C1), centrifugation is performed at a speed of 50 to 1610 ghg for 1 to 10 minutes; the step of removing the supernatant is pipetting the supernatant after centrifugation; then, as a PBS washing step, PBS is added and gently shaken by hand for 20 to 30 seconds, then pipetting the supernatant, and then repeating this PBS washing step once; in the method of harvesting cells on the three-dimensional microcarrier, the ratio of the mass of the three-dimensional microcarrier to the volume of the lysate for cell attachment and culture is 1 mg: 0.01 to 5 mL; incubation is performed at a temperature of 4°C to 40°C for 10 seconds to 24 hours; and in step (C4), centrifugation is performed at a speed of 50 to 1610 ghg for 1 to 10 minutes. Claim 11 In claim 1, a method for sampling cells cultured on a microcarrier to calculate the total number of cells and cell density of cells cultured on the microcarrier comprises: (D1) a step of weighing a certain weight of microcarrier for cell culture and placing it in a sampling tube, wherein a liquid for performing the cell culture process is added after placing the certain weight of microcarrier for cell culture into the sampling tube, and then immersed at 4 to 60°C for 0 to 24 hours, and a scale corresponding to the volume occupied by the microcarrier is marked on the sampling tube as a reference scale; (D2) a step of sampling cells cultured on the microcarrier, wherein the microcarrier is sampled from the cell culture system using a sampling tube so that the volume of the microcarrier reaches the reference scale; (D3) a step of counting the cells within the microcarrier collected in (D2); (D4) includes the step of calculating the cell density by calculating the total number of cells in the entire cell culture system based on the weight of the microcarrier weighed in (D1), the number of cells counted in (D3), and the total weight of the microcarrier in the entire cell culture system; the liquid added in step (D1) has the same or similar viscosity, hydrophilicity, pH, and ion concentration as the medium used for cell culture on the microcarrier, and in step (D1), the ratio of the liquid to the microcarrier is 10 to 1000 μL: 1 mg, and further includes natural precipitation or centrifugal precipitation after immersing the microcarrier in the liquid; and in step (D2), sampling the microcarrier from the cell culture system using a sampling tube is performed according to a method comprising the following steps: picking up the suspension from the cell culture system and adding it to the sampling tube, precipitating the microcarrier by natural precipitation or centrifugal precipitation, and then checking whether the volume of the microcarrier reaches a reference scale set in step (D1);A set of three-dimensional microcarrier-based cell culture methods characterized by the following steps: if the reference scale is not reached, repeating the picketing of the suspension until the reference scale is reached, and if the reference scale is exceeded, removing the excess microcarrier from the sampling tube; in step (D4), the total number of cells in the entire cell culture system is calculated by multiplying the number of cells counted in (D3) by the ratio of the total weight of the microcarrier to the weight of the microcarrier weighed in (D1); and in step (D4), the total number of cells is divided by the total weight of the microcarrier, the total number of microcarriers, or the total volume of the culture system to obtain a cell density in units selected from cell / mg microcarrier, cell / microcarrier, and cell / mL culture system. Claim 12 A set of three-dimensional microcarrier-based cell culture methods according to claim 1, wherein the set of three-dimensional microcarrier-based cell culture methods further comprises a three-dimensional microcarrier-based method for large-scale cell proliferation, and wherein the three-dimensional microcarrier-based method for large-scale cell proliferation comprises the step of large-scale proliferation of cells on a three-dimensional microcarrier in a stirred bioreactor. Claim 13 A set of three-dimensional microcarrier-based cell culture methods according to claim 1, characterized in that the cell is an adherent cell. Claim 14 A set of three-dimensional microcarrier-based cell culture methods according to claim 13, characterized in that the adherent cells are stem cells. Claim 15 delete Claim 16 delete Claim 17 delete Claim 18 delete Claim 19 delete Claim 20 delete Claim 21 delete Claim 22 delete Claim 23 delete Claim 24 delete Claim 25 delete Claim 26 delete Claim 27 delete
Citation Information
Patent Citations
Method for sampling and counting cells cultured on microcarriers
CN110218764A
Methods for identifying modulators of cell signaling
JP2009517072A
Microcarriers for Stem Cell Culture
US20120219531A1
In vitro expansion of postpartum-derived cells using microcarriers
US9102915B2
Biopreserved stem cells on microcarriers
US20180216072A1
